<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created by Certent Disclosure Management 6.23.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 11/6/2018 8:57:06 AM-->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:adus="http://www.addus.com/20180930" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="adus-20180930.xsd" />
  <!--Context Section-->
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_8_20_2018_To_8_20_2018_dei_LegalEntityAxis_adus_EosCapitalPartnersMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_SecondarySharsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:EosCapitalPartnersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">adus:SecondarySharsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-08-20</startDate>
      <endDate>2018-08-20</endDate>
    </period>
  </context>
  <context id="Duration_8_20_2018_To_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_SecondaryPublicOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">adus:SecondaryPublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-08-20</startDate>
      <endDate>2018-08-20</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:SunCitiesHomecareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:LifestyleOptionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_adus_ComputerSoftwareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adus:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_adus_ComputerSoftwareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">adus:ComputerSoftwareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_TransportationEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TransportationEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:DelayedDrawTermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:DelayedDrawTermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_8_22_2018_To_8_22_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-08-22</startDate>
      <endDate>2018-08-22</endDate>
    </period>
  </context>
  <context id="Duration_8_20_2018_To_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_PrimarySharesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">adus:PrimarySharesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-08-20</startDate>
      <endDate>2018-08-20</endDate>
    </period>
  </context>
  <context id="Duration_9_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AffiliateBranchesOfArcadiaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AffiliateBranchesOfArcadiaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-09-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:DelayedDrawTermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-30</instant>
    </period>
  </context>
  <context id="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:TermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-30</instant>
    </period>
  </context>
  <context id="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:DelayedDrawTermLoanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-30</instant>
    </period>
  </context>
  <context id="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:TerminatedSeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:TerminatedSeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-05-07</instant>
    </period>
  </context>
  <context id="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LetterOfCreditMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:TerminatedSeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-05-07</instant>
    </period>
  </context>
  <context id="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_UncommittedIncrementalTermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:TerminatedSeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:UncommittedIncrementalTermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-05-07</instant>
    </period>
  </context>
  <context id="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:TerminatedSeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:DelayedDrawTermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-05-07</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AffiliateBranchesOfArcadiaMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AffiliateBranchesOfArcadiaMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">adus:StateLicensesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_12_31_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_AmendedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:AmendedSeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:DelayedDrawTermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:TerminatedSeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:TermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember_srt_RangeAxis_srt_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FirstAmericanCommercialBancorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember_srt_RangeAxis_srt_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FirstAmericanCommercialBancorpMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_5_1_2018_dei_LegalEntityAxis_adus_FordMotorCreditCompanyLlcMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FordMotorCreditCompanyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-05-01</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:TermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-10-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_DebtInstrumentAxis_adus_SeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:TermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_DebtInstrumentAxis_adus_SeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:SeniorSecuredCreditFacilityMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">adus:TermLoanMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CapitalLeaseObligationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">adus:OneMonthLiborMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableSeniorLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableSeniorLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">adus:OneMonthLiborMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_FederalFundsRateMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">adus:FederalFundsRateMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">adus:OneMonthLiborMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableSeniorLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableSeniorLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:BasedOnApplicableLeverageRatioMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">adus:OneMonthLiborMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_FederalFundsRateMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">adus:FederalFundsRateMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:StateLocalAndOtherGovernmentalProgramsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:PrivatePayMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:OtherMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:OtherMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:OtherMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:MedicareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:MedicareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:CommercialInsuranceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">adus:AllOtherStatesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">adus:IllinoisDepartmentOnAgingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:StateLocalAndOtherGovernmentalProgramsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:PrivatePayMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:OtherMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:OtherMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:OtherMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:MedicareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:MedicareMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:CommercialInsuranceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">adus:AllOtherStatesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HospiceMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:HomeHealthMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">adus:IllinoisDepartmentOnAgingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">adus:IllinoisDepartmentOnAgingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:StateLocalAndOtherGovernmentalProgramsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:PrivatePayMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:CommercialInsuranceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">adus:AllOtherStatesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">adus:IllinoisDepartmentOnAgingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_12_31_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">adus:IllinoisDepartmentOnAgingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-12-31</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:StateLocalAndOtherGovernmentalProgramsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:PrivatePayMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:ManagedCareOrganizationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">adus:CommercialInsuranceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">adus:AllOtherStatesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">adus:PersonalCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueServicesNetMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">adus:IllinoisDepartmentOnAgingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_SecondaryPublicOfferingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">adus:SecondaryPublicOfferingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-08-20</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <instant>2017-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_10_1_2016_dei_LegalEntityAxis_adus_MeridianLeasingCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:MeridianLeasingCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-10-01</instant>
    </period>
  </context>
  <context id="As_Of_4_13_2015_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FirstAmericanCommercialBancorpMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2015-04-13</instant>
    </period>
  </context>
  <context id="As_Of_9_11_2014_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FirstAmericanCommercialBancorpMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-09-11</instant>
    </period>
  </context>
  <context id="As_Of_7_12_2014_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FirstAmericanCommercialBancorpMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-07-12</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_TransportationEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:TransportationEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:LifestyleOptionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AZ</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:SunCitiesHomecareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:LifestyleOptionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AZ</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:SunCitiesHomecareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_5_1_2018_To_5_1_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-05-01</startDate>
      <endDate>2018-05-01</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2018_To_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:ArcadiaHomeCareAndStaffingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-04-01</startDate>
      <endDate>2018-04-01</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:ArcadiaHomeCareAndStaffingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:ArcadiaHomeCareAndStaffingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_10_1_2017_To_10_1_2017_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AZ</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:SunCitiesHomecareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-10-01</startDate>
      <endDate>2017-10-01</endDate>
    </period>
  </context>
  <context id="Duration_8_1_2017_To_8_1_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-08-01</startDate>
      <endDate>2017-08-01</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_10_31_2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <instant>2018-10-31</instant>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:CreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-09-30</instant>
    </period>
  </context>
  <context id="Duration_10_1_2017_To_10_1_2017_dei_LegalEntityAxis_adus_LhcGroupIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:LhcGroupIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-10-01</startDate>
      <endDate>2017-10-01</endDate>
    </period>
  </context>
  <context id="Duration_8_1_2017_To_8_1_2017_srt_RangeAxis_srt_MinimumMember_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-08-01</startDate>
      <endDate>2017-08-01</endDate>
    </period>
  </context>
  <context id="Duration_3_1_2017_To_3_1_2017_srt_StatementGeographicalAxis_stpr_IL">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-03-01</startDate>
      <endDate>2017-03-01</endDate>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="Duration_10_30_2018_To_10_30_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-30</startDate>
      <endDate>2018-10-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">adus:StateLicensesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <instant>2017-12-31</instant>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_9_30_2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <instant>2018-09-30</instant>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_dei_LegalEntityAxis_adus_MeridianLeasingCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:MeridianLeasingCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_dei_LegalEntityAxis_adus_FordMotorCreditCompanyLlcMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FordMotorCreditCompanyLlcMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">adus:FirstAmericanCommercialBancorpMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-05-01</instant>
    </period>
  </context>
  <context id="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:ArcadiaHomeCareAndStaffingMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-04-01</instant>
    </period>
  </context>
  <context id="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:LifestyleOptionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-01-01</instant>
    </period>
  </context>
  <context id="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:SunCitiesHomecareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-10-01</instant>
    </period>
  </context>
  <context id="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:OptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-08-01</instant>
    </period>
  </context>
  <context id="Duration_10_31_2018_To_10_31_2018_us-gaap_BusinessAcquisitionAxis_adus_VipHealthcareServicesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:VipHealthcareServicesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-10-31</startDate>
      <endDate>2018-10-31</endDate>
    </period>
  </context>
  <context id="As_Of_5_1_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareCorporationMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2018-05-01</instant>
    </period>
  </context>
  <context id="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-07-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_7_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-07-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_1_1_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">adus:LifestyleOptionsIncMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-01-01</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_9_30_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-09-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_RestrictionOnDividendsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001468328</identifier>
      <segment>
        <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">adus:NewCreditAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">adus:CapitalOneMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">adus:RestrictionOnDividendsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2018-01-01</startDate>
      <endDate>2018-09-30</endDate>
    </period>
  </context>
  <!--Unit Section-->
  <unit id="Unit18">
    <measure>adus:segment</measure>
  </unit>
  <unit id="Unit17">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Unit16">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="Unit15">
    <measure>adus:entity</measure>
  </unit>
  <unit id="Unit14">
    <measure>adus:agreement</measure>
  </unit>
  <unit id="Unit13">
    <measure>adus:item</measure>
  </unit>
  <unit id="Unit12">
    <measure>xbrli:pure</measure>
  </unit>
  <unit id="Unit1">
    <measure>iso4217:USD</measure>
  </unit>
  <!--Tuple Section-->
  <!--Element Section-->
  <adus:AggregateAmountOfDividendsAndDistributions id="Item-518" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_RestrictionOnDividendsMember" unitRef="Unit1" decimals="-5">7500000</adus:AggregateAmountOfDividendsAndDistributions>
  <adus:AmortizationOfDebtIssuanceCostsUnderNewCreditFacility id="Item-212" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">235000</adus:AmortizationOfDebtIssuanceCostsUnderNewCreditFacility>
  <adus:AmortizationOfDebtIssuanceCostsUnderNewCreditFacility id="Item-211" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">450000</adus:AmortizationOfDebtIssuanceCostsUnderNewCreditFacility>
  <adus:BusinessAcquisitionContingentEarnOutObligation id="Item-28" contextRef="Duration_1_1_2018_To_1_1_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-5">800000</adus:BusinessAcquisitionContingentEarnOutObligation>
  <adus:BusinessAcquisitionProFormaOperatingIncome id="Item-101" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">25336000</adus:BusinessAcquisitionProFormaOperatingIncome>
  <adus:BusinessAcquisitionProFormaOperatingIncome id="Item-91" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">8418000</adus:BusinessAcquisitionProFormaOperatingIncome>
  <adus:BusinessAcquisitionProFormaOperatingIncome id="Item-100" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">28833000</adus:BusinessAcquisitionProFormaOperatingIncome>
  <adus:BusinessAcquisitionProFormaOperatingIncome id="Item-90" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">7758000</adus:BusinessAcquisitionProFormaOperatingIncome>
  <adus:BusinessCombinationPurchasePriceCreditEstimatedExcessCashHeldAtClosing id="Item-43" contextRef="As_Of_5_1_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">12000000</adus:BusinessCombinationPurchasePriceCreditEstimatedExcessCashHeldAtClosing>
  <adus:BusinessCombinationPurchasePriceOfEntityToBeAcquired id="Item-889" contextRef="Duration_10_31_2018_To_10_31_2018_us-gaap_BusinessAcquisitionAxis_adus_VipHealthcareServicesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">28000000</adus:BusinessCombinationPurchasePriceOfEntityToBeAcquired>
  <adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities id="Item-41" contextRef="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-3">701000</adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities>
  <adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities id="Item-10" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">86000</adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities>
  <adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities id="Item-24" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">291000</adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities>
  <adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities id="Item-84" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">1540000</adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities>
  <adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities id="Item-66" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">3732000</adus:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities>
  <adus:CapitalLeaseTerm id="Item-521" contextRef="Duration_1_1_2018_To_9_30_2018_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember">P48M</adus:CapitalLeaseTerm>
  <adus:CapitalLeaseTerm id="Item-464" contextRef="Duration_1_1_2018_To_9_30_2018_dei_LegalEntityAxis_adus_FordMotorCreditCompanyLlcMember">P48M</adus:CapitalLeaseTerm>
  <adus:CapitalLeaseTerm id="Item-483" contextRef="Duration_1_1_2018_To_9_30_2018_dei_LegalEntityAxis_adus_MeridianLeasingCorporationMember">P25M</adus:CapitalLeaseTerm>
  <adus:ConcentrationOfCashDisclosureTextBlock id="Item-201" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;13. Concentration of Cash&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash. The Company maintains cash with financial institutions which, at times, may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk on cash.&lt;/font&gt;&lt;/p&gt; &lt;/div&gt;</adus:ConcentrationOfCashDisclosureTextBlock>
  <adus:ContingentAndDeferredConsiderationAccruedForAcquisitions id="Item-260" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">847000</adus:ContingentAndDeferredConsiderationAccruedForAcquisitions>
  <adus:ContingentEarnOutObligatioCurrent id="Item-135" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">847000</adus:ContingentEarnOutObligatioCurrent>
  <adus:ContributionsDueAfterFundReceivedPeriod id="Item-174" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL">P5D</adus:ContributionsDueAfterFundReceivedPeriod>
  <adus:DeductibleComponentOfWorkersCompensation id="Item-723" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">400000</adus:DeductibleComponentOfWorkersCompensation>
  <adus:DetailsOfCertainBalanceSheetAccountsDisclosureTextBlock id="Item-159" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;6. Details of Certain Balance Sheet Accounts&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prepaid expenses and other current assets consisted of the following:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="55%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="12%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="17%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;December 31, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 3px;" colspan="3" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prepaid health insurance&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,457&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,901&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Workers' compensation insurance receivable&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,375&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;543&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prepaid rent&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,208&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;555&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prepaid workers' compensation and liability&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;insurance&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,251&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,332&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,644&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,048&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,935&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;8,379&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p&gt;&lt;a name="page_17"&gt; &lt;/a&gt;&lt;/p&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued expenses consisted of the following:&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="5"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;December 31, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued payroll&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 3px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;27,236&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;19,783&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued workers' compensation insurance&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,846&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,574&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued health insurance (1)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,165&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,471&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued professional fees&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,242&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,312&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued payroll taxes&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,540&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,065&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,407&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,149&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;52,436&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;44,354&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;&lt;a name="page_18"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1) &lt;font class="_mt"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company provides health insurance coverage to qualified union employees providing personal care services in Illinois through a Taft-Hartley multi-employer health and welfare plan under Section 302(c)(5) of the Labor Management Relations Act of 1947. The Company's insurance contributions equal the amount reimbursed by the State of Illinois. Contributions are due within&amp;nbsp;&lt;font class="_mt"&gt;five&lt;/font&gt; business days from the date the funds are received from the State of Illinois. &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Amounts due of $&lt;font class="_mt"&gt;1.2&lt;/font&gt; million and $&lt;font class="_mt"&gt;2.3&lt;/font&gt; million for health insurance reimbursements and contributions were reflected in prepaid insurance and accrued insurance as of September 30, 2018 and December 31, 2017, respectively.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</adus:DetailsOfCertainBalanceSheetAccountsDisclosureTextBlock>
  <adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet id="Item-358" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">-0.075</adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet>
  <adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet id="Item-347" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">-0.077</adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet>
  <adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet id="Item-357" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">-0.093</adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet>
  <adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet id="Item-346" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">-0.100</adus:EffectiveIncomeTaxRateReconciliationJobsTaxCreditsNet>
  <adus:GainOnSaleOfAssetsDisclosureTextBlock id="Item-274" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;3. Gain on Sale of Assets&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Given the Company's focus on providing services to consumers in their homes, effective March 1, 2017, the Company ceased the adult day services business and completed its sale of substantially all of the assets used in&amp;nbsp;&lt;font class="_mt"&gt;three&lt;/font&gt; adult day services centers in Illinois. The Company received proceeds of approximately $&lt;font class="_mt"&gt;2.4&lt;/font&gt; million and recorded a pre-tax gain of $&lt;font class="_mt"&gt;2.1&lt;/font&gt; million on the sale of the&amp;nbsp;&lt;font class="_mt"&gt;three&lt;/font&gt; adult day services centers.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On October 1, 2017, the Company sold its &lt;font class="_mt"&gt;10&lt;/font&gt;% membership interests in&amp;nbsp;&lt;font class="_mt"&gt;two&lt;/font&gt; joint ventures with LHC Group, Inc., which were previously reported as Investments in joint ventures on the Company's Unaudited Condensed Consolidated Balance Sheets at September 30, 2017. The Company received proceeds of approximately $&lt;font class="_mt"&gt;1.3&lt;/font&gt; million and recorded a pre-tax gain of $&lt;font class="_mt"&gt;0.4&lt;/font&gt; million on the sale of its membership interests.&lt;/font&gt;&lt;/p&gt; &lt;/div&gt;</adus:GainOnSaleOfAssetsDisclosureTextBlock>
  <adus:GoingConcernPolicyTextBlock id="Item-736" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Going Concern&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In connection with the preparation of the financial statements for the three and nine months ended September 30, 2018 and 2017, the Company conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to the entity's ability to continue as a going concern within one year after the date of the issuance, or the date of availability, of the financial statements to be issued. The evaluation concluded that there did not appear to be evidence of substantial doubt of the entity's ability to continue as a going concern.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</adus:GoingConcernPolicyTextBlock>
  <adus:HealthInsuranceReimbursementAndContributionDue id="Item-188" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-5">2300000</adus:HealthInsuranceReimbursementAndContributionDue>
  <adus:HealthInsuranceReimbursementAndContributionDue id="Item-189" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-5">1200000</adus:HealthInsuranceReimbursementAndContributionDue>
  <adus:IntangibleAssetsAdditionsForAcquisitions id="Item-314" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">14512000</adus:IntangibleAssetsAdditionsForAcquisitions>
  <adus:IntangibleAssetsAdditionsForAcquisitions id="Item-313" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember" unitRef="Unit1" decimals="-3">2376000</adus:IntangibleAssetsAdditionsForAcquisitions>
  <adus:IntangibleAssetsAdditionsForAcquisitions id="Item-311" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="Unit1" decimals="-3">5209000</adus:IntangibleAssetsAdditionsForAcquisitions>
  <adus:IntangibleAssetsAdditionsForAcquisitions id="Item-312" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="Unit1" decimals="-3">6927000</adus:IntangibleAssetsAdditionsForAcquisitions>
  <adus:InterestIncomePolicyTextBlock id="Item-740" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Interest Income&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Illinois law entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. The Company accounted for the interest income in accordance with ASC 606.&amp;nbsp;The interest income was recognized when the State of Illinois approved a prompt payment interest penalty during the nine months ended September 30, 2018, removing the constraint related to the amount and intent to pay the prompt payment interest. For the three months ended September 30, 2018, the Company did not receive any prompt payment interest. For the nine months ended September 30, 2018, the Company received $&lt;font class="_mt"&gt;2.3&lt;/font&gt; million in prompt payment interest and reported it in its Unaudited Condensed Consolidated Statements of Income as interest income. For the three and nine months ended September 30, 2017, the Company did &lt;font class="_mt"&gt;no&lt;/font&gt;t receive any prompt payment interest. While the Company may be owed additional prompt payment interest in the future, the amount, timing, and intent to provide receipt of such payments remains uncertain, and the Company will continue to recognize prompt payment interest income upon satisfaction of these constraints.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</adus:InterestIncomePolicyTextBlock>
  <adus:LeverageRatio id="Item-512" contextRef="Duration_10_30_2018_To_10_30_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0425</adus:LeverageRatio>
  <adus:LeverageRatio id="Item-510" contextRef="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0375</adus:LeverageRatio>
  <adus:NumberOfAdultDayCentersSold id="Item-280" contextRef="Duration_3_1_2017_To_3_1_2017_srt_StatementGeographicalAxis_stpr_IL" unitRef="Unit13" decimals="INF">3</adus:NumberOfAdultDayCentersSold>
  <adus:NumberOfCapitalLeaseAgreement id="Item-496" contextRef="Duration_1_1_2018_To_9_30_2018_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember" unitRef="Unit14" decimals="INF">3</adus:NumberOfCapitalLeaseAgreement>
  <adus:NumberOfCountiesUnderPersonalCareServices id="Item-52" contextRef="Duration_8_1_2017_To_8_1_2017_srt_RangeAxis_srt_MinimumMember_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit13" decimals="INF">20</adus:NumberOfCountiesUnderPersonalCareServices>
  <adus:NumberOfJointVenturesWhereTenPercentMembershipInterestSold id="Item-282" contextRef="Duration_10_1_2017_To_10_1_2017_dei_LegalEntityAxis_adus_LhcGroupIncMember" unitRef="Unit15" decimals="INF">2</adus:NumberOfJointVenturesWhereTenPercentMembershipInterestSold>
  <adus:NumberOfStockIncentivePlans id="Item-733" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit13" decimals="0">1</adus:NumberOfStockIncentivePlans>
  <adus:NumberOfStockOptionsIncludedInCalculation id="Item-741" contextRef="As_Of_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit16" decimals="-3">479000</adus:NumberOfStockOptionsIncludedInCalculation>
  <adus:NumberOfStockOptionsIncludedInCalculation id="Item-717" contextRef="As_Of_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit16" decimals="-3">708000</adus:NumberOfStockOptionsIncludedInCalculation>
  <adus:OtherIncomePolicyTextBlock id="Item-732" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Other Income&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other income consisted of income distributions received from investments in joint ventures. The Company accounted for this income in accordance with ASC Topic 325, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Investments&amp;#8212;Other. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company recognized the net accumulated &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;earnings only to the extent distributed by the joint ventures on the date received. The Company subsequently sold these equity investments on October 1, 2017 (see Note 3).&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</adus:OtherIncomePolicyTextBlock>
  <adus:PercentageOfEquityOwnershipSold id="Item-279" contextRef="Duration_10_1_2017_To_10_1_2017_dei_LegalEntityAxis_adus_LhcGroupIncMember" unitRef="Unit12" decimals="2">0.10</adus:PercentageOfEquityOwnershipSold>
  <adus:PrepaidWorkersCompensationAndLiabilityInsuranceCurrent id="Item-183" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">1332000</adus:PrepaidWorkersCompensationAndLiabilityInsuranceCurrent>
  <adus:PrepaidWorkersCompensationAndLiabilityInsuranceCurrent id="Item-182" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1251000</adus:PrepaidWorkersCompensationAndLiabilityInsuranceCurrent>
  <adus:RepaymentsOfRevolverTerminatedCreditFacility id="Item-238" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">20000000</adus:RepaymentsOfRevolverTerminatedCreditFacility>
  <adus:RepaymentsOfTermLoanCreditFacility id="Item-240" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">1688000</adus:RepaymentsOfTermLoanCreditFacility>
  <adus:ScheduleOfPropertyPlantAndEquipmentTableTextBlock id="Item-696" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="44%"&gt; &lt;/td&gt;
&lt;td width="55%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="44%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;
&lt;td width="55%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3 &amp;#8211; 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="44%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td width="55%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 &amp;#8211; 7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="44%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Transportation equipment&lt;/font&gt;&lt;/td&gt;
&lt;td width="55%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="44%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer software&lt;/font&gt;&lt;/td&gt;
&lt;td width="55%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 &amp;#8211; 10 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="44%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;
&lt;td width="55%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Lesser of useful life or lease term, unless&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="44%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="55%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;probability of lease renewal is likely&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;/div&gt;</adus:ScheduleOfPropertyPlantAndEquipmentTableTextBlock>
  <adus:TaxCutsAndJobsActOf2017ChangeInTaxRateIncreaseInProvisionalValuationAllowance id="Item-337" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">400000</adus:TaxCutsAndJobsActOf2017ChangeInTaxRateIncreaseInProvisionalValuationAllowance>
  <adus:TaxCutsAndJobsActOf2017ChangeInTaxRateIncreaseInProvisionalValuationAllowance id="Item-340" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">200000</adus:TaxCutsAndJobsActOf2017ChangeInTaxRateIncreaseInProvisionalValuationAllowance>
  <adus:TermOfEmploymentAgreementsMaximum id="Item-200" contextRef="Duration_1_1_2018_To_9_30_2018">P4Y</adus:TermOfEmploymentAgreementsMaximum>
  <adus:TotalIndebtednessLessSubordinatedIndebtednessToConsolidatedAdjustedEbitda id="Item-465" contextRef="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0425</adus:TotalIndebtednessLessSubordinatedIndebtednessToConsolidatedAdjustedEbitda>
  <adus:WorkersCompensationInsuranceReceivable id="Item-179" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">543000</adus:WorkersCompensationInsuranceReceivable>
  <adus:WorkersCompensationInsuranceReceivable id="Item-178" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1375000</adus:WorkersCompensationInsuranceReceivable>
  <dei:AmendmentFlag id="Item-895" contextRef="Duration_1_1_2018_To_9_30_2018">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate id="Item-894" contextRef="Duration_1_1_2018_To_9_30_2018">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus id="Item-893" contextRef="Duration_1_1_2018_To_9_30_2018">Q3</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus id="Item-892" contextRef="Duration_1_1_2018_To_9_30_2018">2018</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate id="Item-891" contextRef="Duration_1_1_2018_To_9_30_2018">2018-09-30</dei:DocumentPeriodEndDate>
  <dei:DocumentType id="Item-890" contextRef="Duration_1_1_2018_To_9_30_2018">10-Q</dei:DocumentType>
  <dei:EntityCentralIndexKey id="Item-896" contextRef="Duration_1_1_2018_To_9_30_2018">0001468328</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding id="Item-273" contextRef="As_Of_10_31_2018" unitRef="Unit16" decimals="INF">13098355</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityEmergingGrowthCompany id="Item-271" contextRef="Duration_1_1_2018_To_9_30_2018">false</dei:EntityEmergingGrowthCompany>
  <dei:EntityFilerCategory id="Item-898" contextRef="Duration_1_1_2018_To_9_30_2018">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityRegistrantName id="Item-897" contextRef="Duration_1_1_2018_To_9_30_2018">Addus HomeCare Corp</dei:EntityRegistrantName>
  <dei:EntitySmallBusiness id="Item-270" contextRef="Duration_1_1_2018_To_9_30_2018">false</dei:EntitySmallBusiness>
  <dei:TradingSymbol id="Item-899" contextRef="Duration_1_1_2018_To_9_30_2018">adus</dei:TradingSymbol>
  <us-gaap:AccountsPayableCurrent id="Item-132" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">4271000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="Item-131" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">6737000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="Item-115" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">88952000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="Item-114" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">106653000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedInsuranceCurrent id="Item-165" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">6471000</us-gaap:AccruedInsuranceCurrent>
  <us-gaap:AccruedInsuranceCurrent id="Item-164" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">4165000</us-gaap:AccruedInsuranceCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Item-173" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">44354000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="Item-172" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">52436000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedPayrollTaxesCurrent id="Item-169" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">1065000</us-gaap:AccruedPayrollTaxesCurrent>
  <us-gaap:AccruedPayrollTaxesCurrent id="Item-168" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1540000</us-gaap:AccruedPayrollTaxesCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent id="Item-167" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">1312000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:AccruedProfessionalFeesCurrent id="Item-166" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1242000</us-gaap:AccruedProfessionalFeesCurrent>
  <us-gaap:AccruedSalariesCurrent id="Item-161" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">19783000</us-gaap:AccruedSalariesCurrent>
  <us-gaap:AccruedSalariesCurrent id="Item-160" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">27236000</us-gaap:AccruedSalariesCurrent>
  <us-gaap:AdditionalPaidInCapital id="Item-152" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">95963000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital id="Item-151" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">175991000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Item-873" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">2961000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue id="Item-872" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="-3">2961000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Item-724" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">1800000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Item-735" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">700000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Item-739" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="Item-750" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts id="Item-210" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">1484000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:AmortizationOfIntangibleAssets id="Item-285" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">3300000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets id="Item-286" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">1200000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets id="Item-288" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">4900000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets id="Item-289" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">1900000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:Assets id="Item-130" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">267110000</us-gaap:Assets>
  <us-gaap:Assets id="Item-129" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">430778000</us-gaap:Assets>
  <us-gaap:AssetsCurrent id="Item-119" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">151085000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="Item-118" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">261065000</us-gaap:AssetsCurrent>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic id="Item-105" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">0.80</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic id="Item-95" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">0.29</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic id="Item-104" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">1.57</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic id="Item-94" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">0.44</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted id="Item-107" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">0.78</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted id="Item-97" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">0.29</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted id="Item-106" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">1.53</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted id="Item-96" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit17" decimals="2">0.42</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
  <us-gaap:BusinessAcquisitionProFormaInformationTextBlock id="Item-108" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember">&lt;div&gt; &lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt; &lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;137,631&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;135,440&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;8,418&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,332&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,317&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income per common share&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Basic income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.44&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.29&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Diluted income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.42&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.29&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;410,552&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;398,948&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;28,833&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;25,336&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,415&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;9,118&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income per common share&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Basic income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.57&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Diluted income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.53&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.78&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt; &lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss id="Item-103" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">9118000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss id="Item-93" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">3317000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss id="Item-102" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">18415000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss id="Item-92" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">5332000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaRevenue id="Item-99" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">398948000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionsProFormaRevenue id="Item-89" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">135440000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionsProFormaRevenue id="Item-98" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">410552000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessAcquisitionsProFormaRevenue id="Item-88" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareArcadiaLifestyleSunCitiesAndOptionsHomeCareMember" unitRef="Unit1" decimals="-3">137631000</us-gaap:BusinessAcquisitionsProFormaRevenue>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="Item-59" contextRef="Duration_8_1_2017_To_8_1_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">800000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="Item-18" contextRef="Duration_10_1_2017_To_10_1_2017_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-5">200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="Item-72" contextRef="Duration_1_1_2018_To_1_1_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">48000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="Item-54" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-5">1400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="Item-53" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">1400000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="Item-2" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-5">800000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts id="Item-74" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">800000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationConsiderationTransferred1 id="Item-58" contextRef="Duration_8_1_2017_To_8_1_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">22600000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferred1 id="Item-55" contextRef="Duration_10_1_2017_To_10_1_2017_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-5">2300000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferred1 id="Item-75" contextRef="Duration_1_1_2018_To_1_1_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-5">4100000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferred1 id="Item-77" contextRef="Duration_4_1_2018_To_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-5">18900000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferred1 id="Item-56" contextRef="Duration_5_1_2018_To_5_1_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">39600000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationDisclosureTextBlock id="Item-1" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;4. Acquisitions&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On May 1, 2018, the Company completed its acquisition of all the outstanding securities of Ambercare Corporation ("Ambercare"). The purchase price was approximately $&lt;font class="_mt"&gt;39.6&lt;/font&gt; million plus the amount of excess cash held by Ambercare at closing (approximately $&lt;font class="_mt"&gt;12.0&lt;/font&gt; million). The purchase of Ambercare was funded by a delayed draw term loan under the Company's credit facility. With the purchase of Ambercare, the Company expanded its personal care operations and acquired hospice and home health operations in the State of New Mexico. Following this acquisition the Company operates a hospice segment and home health segment. The related acquisition costs, included in general and administrative expenses on the Company's Unaudited Condensed Consolidated Statements of Income, were $&lt;font class="_mt"&gt;0.8&lt;/font&gt; million and&amp;nbsp;&lt;font class="_mt"&gt;$1.4&lt;/font&gt; million, for the three and nine months ending September 30, 2018, respectively, and were expensed as incurred. The results of Ambercare are included on the Company's Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's acquisition of Ambercare has been accounted for in accordance with ASC Topic 805, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Business Combinations&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, and the resulting goodwill and other intangible assets was accounted for under ASC Topic 350, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill and Other Intangible Assets&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;. The acquisition was recorded at its fair value as of May 1, 2018. Under business combination accounting, the Ambercare purchase price was $51.6 million and was allocated to Ambercare's net tangible and identifiable intangible assets based on their estimated fair values. Based upon management's valuation, which is preliminary and subject to completion of working capital adjustments, the total purchase price has been allocated as follows:&lt;/font&gt;&lt;/p&gt;&lt;a name="page_13"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="56%"&gt; &lt;/td&gt;
&lt;td width="23%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;28,082&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cash&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,008&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10,413&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,638&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;440&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;171&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(3,732&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Deferred tax liability&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,302&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Capital lease&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(93&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;51,622&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Management's assessment of qualitative factors affecting goodwill for Ambercare includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations, and the payor profile in the market.&lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; The Company acquired the outstanding stock of Ambercare. Identifiable intangible assets acquired consist of trade names, customer relationships and state licenses (see Note 2 for estimated useful lives of the Company's identifiable intangible assets). The preliminary estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist.&amp;nbsp;The&amp;nbsp;goodwill and intangible assets acquired are non-deductible for tax purposes.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Ambercare acquisition accounted for $&lt;font class="_mt"&gt;13.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;22.6&lt;/font&gt; million of net service revenues and $&lt;font class="_mt"&gt;2.0&lt;/font&gt; million and $&lt;font class="_mt"&gt;3.8&lt;/font&gt; million of net income prior to corporate allocation for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On April 1, 2018, the Company acquired certain assets of Arcadia Home Care &amp;amp; Staffing ("Arcadia"), expanding its personal care services. The total consideration for the transaction was $&lt;font class="_mt"&gt;18.9&lt;/font&gt; million and was funded by a delayed draw term loan under the Company's credit facility. The related acquisition costs, included in general and administrative expenses on the Company's Unaudited Condensed Consolidated Statements of Income, were $&lt;font class="_mt"&gt;0.8&lt;/font&gt; million and $&lt;font class="_mt"&gt;1.4&lt;/font&gt; million for the three and nine months ending September 30, 2018, respectively, and were expensed as incurred. The results of operations from this acquired entity are included in the Company's Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's acquisition of Arcadia has been accounted for in accordance with ASC Topic 805 and the resulting goodwill and other intangible assets was accounted for under ASC Topic 350. The acquisition was recorded at its fair value as of April 1, 2018. Under business combination accounting, the Arcadia purchase price was $18.9 million and was allocated to Arcadia's net tangible and identifiable intangible assets based on their estimated fair values. Based upon management's valuation, which is preliminary and subject to completion of working capital and other adjustments, the total purchase price has been allocated as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="54%"&gt; &lt;/td&gt;
&lt;td width="22%"&gt; &lt;/td&gt;
&lt;td width="18%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 2px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,389&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,317&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,947&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;155&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;92&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,540&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(508&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,852&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Management's assessment of qualitative factors affecting goodwill for Arcadia includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations, and the payor profile in the market.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets acquired consist of trade name, customer relationships and state licenses (see Note 2 for estimated useful lives of the Company's identifiable intangible assets). The preliminary estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The goodwill and intangible assets acquired are deductible for tax purposes.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Arcadia acquisition accounted for $&lt;font class="_mt"&gt;10.9&lt;/font&gt; million and $&lt;font class="_mt"&gt;21.7&lt;/font&gt; million of net service revenues and $&lt;font class="_mt"&gt;1.6&lt;/font&gt; million and $&lt;font class="_mt"&gt;3.2&lt;/font&gt; million of net income prior to corporate allocation for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In September 2018, the Company acquired certain assets of affiliate branches of Arcadia for&amp;nbsp;&lt;font class="_mt"&gt;$0.6&lt;/font&gt; million using cash on hand, the Company recorded goodwill of&amp;nbsp;&lt;font class="_mt"&gt;$0.6&lt;/font&gt; million on the Company's Unaudited Condensed Consolidated Balance Sheets. Goodwill generated from the acquisition is primarily attributable to expected synergies with existing Company operations and the goodwill and intangible assets acquired are deductible for tax purposes. Pro forma results of the operations related to the acquisition are not included in the pro forma presentation as they are not material to the Company's Unaudited Condensed Consolidated Statements of Income.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective January 1, 2018, the Company acquired certain assets of LifeStyle Options, Inc. ("LifeStyle") in order to expand private pay services in Illinois. The total consideration for the transaction was $&lt;font class="_mt"&gt;4.1&lt;/font&gt; million, comprised of $&lt;font class="_mt"&gt;3.3&lt;/font&gt; million in cash and $&lt;font class="_mt"&gt;0.8&lt;/font&gt; million, representing the preliminary&amp;nbsp;estimated fair value of contingent consideration, subject to the achievement of certain performance targets set forth in an earn-out agreement. The related acquisition costs, included in general and administrative expenses on the Company's Unaudited Condensed Consolidated Statements of Income, were $&lt;font class="_mt"&gt;48,000&lt;/font&gt; and were expensed as incurred. The results of operations from this acquired entity are included in the Company's Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's acquisition of LifeStyle has been accounted for in accordance with ASC Topic 805 and the resulting goodwill and other intangible assets was accounted for under ASC Topic 350. The acquisition was recorded at its fair value as of January 1, 2018. Under business combination accounting, the LifeStyle purchase price was $4.1 million and was allocated to LifeStyle's net tangible and identifiable intangible assets based on their estimated fair values. Based upon management's valuation, the total purchase price has been allocated as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="54%"&gt; &lt;/td&gt;
&lt;td width="22%"&gt; &lt;/td&gt;
&lt;td width="17%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 4px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,751&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,152&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;573&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(291&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(105&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Management's assessment of qualitative factors affecting goodwill for LifeStyle includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations, and the payor profile in the market.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets acquired consist of trade name and customer relationships (see Note 2 for estimated useful lives of the Company's identifiable intangible assets). The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The goodwill and intangible assets acquired are deductible for tax purposes.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The LifeStyle acquisition accounted for $&lt;font class="_mt"&gt;1.5&lt;/font&gt; million and $&lt;font class="_mt"&gt;4.5&lt;/font&gt; million of net service revenues and $&lt;font class="_mt"&gt;0.1&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.4&lt;/font&gt; million of net income prior to corporate allocation for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective October 1, 2017, the Company acquired certain assets of Community Partnered Resources, Inc. d/b/a Sun Cities Caregivers and d/b/a Sun Cities Homecare ("Sun Cities"), in the State of Arizona, to enhance operations in a target market. The total consideration for the transaction was comprised of $&lt;font class="_mt"&gt;2.3&lt;/font&gt; million in cash. The related acquisition costs, included in general and administrative expenses on the Company's Unaudited Condensed Consolidated Statements of Income, were $&lt;font class="_mt"&gt;0.2&lt;/font&gt; million and were expensed as incurred. The results of operations from this acquired entity are included in the Company's Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's acquisition of Sun Cities has been accounted for in accordance with ASC Topic 805 and the resulting goodwill and other intangible assets was accounted for under ASC Topic 350. The acquisition was recorded at its fair value as of October 1, 2017. Under business combination accounting, the Sun Cities purchase price was $2.3 million and was allocated to net tangible and identifiable intangible assets of Sun Cities based on their estimated fair values. Based upon management's valuation, the total purchase price has been allocated as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div&gt;&amp;nbsp;&lt;/div&gt;&lt;a name="page_15"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="56%"&gt; &lt;/td&gt;
&lt;td width="23%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,089&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;682&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;254&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cash&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;321&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(86&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(14&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,256&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Management's assessment of qualitative factors affecting goodwill for Sun Cities includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations, and the payor profile in the market.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets acquired consist of trade name and customer relationships (see Note 2 for estimated useful lives of the Company's identifiable intangible assets). The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The goodwill and intangible assets acquired are deductible for tax purposes.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Sun Cities acquisition accounted for $&lt;font class="_mt"&gt;0.7&lt;/font&gt; million and&amp;nbsp;&lt;font class="_mt"&gt;$1.8&lt;/font&gt; million of net service revenues and $&lt;font class="_mt"&gt;0.1&lt;/font&gt; million of net income prior to corporate allocation for both the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On April 24, 2017, the Company entered into a definitive securities purchase agreement with HB Management Group, Inc. to purchase Options Services, Inc. d/b/a Options Home Care ("Options Home Care"). On August 1, 2017, the Company completed its acquisition of all the outstanding securities of Options Home Care for a total purchase price of $&lt;font class="_mt"&gt;22.6&lt;/font&gt; million. Options Home Care was a provider of personal care services in more than&amp;nbsp;&lt;font class="_mt"&gt;20&lt;/font&gt; counties in New Mexico and the acquisition expanded the footprint of the Company's existing operations in the state. The related acquisition costs, included in general and administrative expenses on the Company's Unaudited Condensed Consolidated Statements of Income, were $&lt;font class="_mt"&gt;0.8&lt;/font&gt; million and were expensed as incurred. The results of Options Home Care are included on the Company's Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's acquisition of Options Home Care has been accounted for in accordance with ASC Topic 805 and the resulting goodwill and other intangible assets was accounted for under ASC Topic 350. The acquisition was recorded at its fair value as of August 1, 2017. Under business combination accounting, the Options purchase price was $22.6 million and was allocated to Options Home Care's net tangible and identifiable intangible assets based on their estimated fair values. Based upon management's valuation, the total purchase price has been allocated as follows:&lt;/font&gt;&lt;/p&gt;&lt;a name="page_16"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="56%"&gt; &lt;/td&gt;
&lt;td width="23%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,671&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,324&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,084&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cash&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;205&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;41&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(701&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;22,624&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Management's assessment of qualitative factors affecting goodwill for Options Home Care includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations, and, the payor profile in the market.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets acquired consist of trade names and customer relationships (see Note 2 for estimated useful lives of the Company's identifiable intangible assets). The estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist. The goodwill and intangible assets acquired are deductible for tax purposes.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Options Home Care acquisition accounted for $&lt;font class="_mt"&gt;4.5&lt;/font&gt; million and $&lt;font class="_mt"&gt;3.3&lt;/font&gt; million of net service revenues and $&lt;font class="_mt"&gt;0.9&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.2&lt;/font&gt; million of net income prior to corporate allocation for the three months ended September 30, 2018 and 2017, respectively and accounted for $&lt;font class="_mt"&gt;13.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;3.3&lt;/font&gt; million of net service revenues and $&lt;font class="_mt"&gt;2.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.2&lt;/font&gt; million of net income prior to corporate allocation for the nine months ended September 30, 2018 and 2017.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The following table contains unaudited pro forma condensed consolidated income statement information of the Company had the acquisitions of Ambercare, Arcadia, LifeStyle, Sun Cities and Options Home Care closed on January 1, 2017.&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="42%"&gt; &lt;/td&gt;
&lt;td width="13%"&gt; &lt;/td&gt;
&lt;td width="19%"&gt; &lt;/td&gt;
&lt;td width="14%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;137,631&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;135,440&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;8,418&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,332&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,317&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income per common share&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Basic income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.44&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.29&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Diluted income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.42&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.29&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;410,552&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;398,948&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;28,833&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;25,336&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,415&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;9,118&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net income per common share&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Basic income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.57&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.80&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 6px;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Diluted income per share&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.53&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.78&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The pro forma disclosures in the table above include adjustments for amortization of intangible assets, tax expense and acquisition costs to reflect results that are more representative of the combined results of the transactions as if Ambercare, Arcadia, LifeStyle, Sun Cities and Options Home Care had been acquired effective January 1, 2017. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operations that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information. The unaudited pro forma financial information does not reflect the impact of future events that may occur after the acquisition, such as anticipated cost savings from operating synergies.&lt;/font&gt;&lt;/p&gt; &lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation id="Item-68" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">93000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents id="Item-39" contextRef="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-3">205000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents id="Item-8" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">321000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents id="Item-61" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">12008000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther id="Item-40" contextRef="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-3">41000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther id="Item-9" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther id="Item-22" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">32000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther id="Item-83" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">92000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther id="Item-64" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">440000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables id="Item-38" contextRef="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-3">1084000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables id="Item-7" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">254000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables id="Item-21" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">573000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables id="Item-80" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">5317000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables id="Item-63" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">6638000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable id="Item-11" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">14000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable id="Item-25" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">105000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable id="Item-85" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">508000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable id="Item-69" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">3000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities id="Item-67" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">2302000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill id="Item-37" contextRef="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-3">5324000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill id="Item-6" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">682000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill id="Item-20" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">1152000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill id="Item-81" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">2947000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill id="Item-62" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">10413000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment id="Item-23" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">18000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment id="Item-82" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">155000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment id="Item-65" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">171000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet id="Item-42" contextRef="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-3">22624000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet id="Item-12" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">2256000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet id="Item-26" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">4130000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet id="Item-86" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">18852000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet id="Item-70" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">51622000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-16" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">200000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-27" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">200000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-3" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">3800000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-17" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-5">3200000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-49" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-5">100000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-47" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-5">400000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-46" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">2400000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-87" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">2000000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-32" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-5">1600000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-50" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-5">100000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-29" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-5">100000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses id="Item-4" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">900000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses>
  <us-gaap:CapitalLeasedAssetsGross id="Item-480" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">3397000</us-gaap:CapitalLeasedAssetsGross>
  <us-gaap:CapitalLeasedAssetsGross id="Item-477" contextRef="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" unitRef="Unit1" decimals="-3">635000</us-gaap:CapitalLeasedAssetsGross>
  <us-gaap:CapitalLeasedAssetsGross id="Item-476" contextRef="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="Unit1" decimals="-3">868000</us-gaap:CapitalLeasedAssetsGross>
  <us-gaap:CapitalLeasedAssetsGross id="Item-475" contextRef="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" unitRef="Unit1" decimals="-3">1484000</us-gaap:CapitalLeasedAssetsGross>
  <us-gaap:CapitalLeasedAssetsGross id="Item-478" contextRef="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="Unit1" decimals="-3">303000</us-gaap:CapitalLeasedAssetsGross>
  <us-gaap:CapitalLeasedAssetsGross id="Item-479" contextRef="As_Of_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_TransportationEquipmentMember" unitRef="Unit1" decimals="-3">107000</us-gaap:CapitalLeasedAssetsGross>
  <us-gaap:CapitalLeaseObligationsCurrent id="Item-492" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">114000</us-gaap:CapitalLeaseObligationsCurrent>
  <us-gaap:CapitalLeaseObligationsNoncurrent id="Item-515" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">28000</us-gaap:CapitalLeaseObligationsNoncurrent>
  <us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet id="Item-482" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1625000</us-gaap:CapitalLeasesBalanceSheetAssetsByMajorClassNet>
  <us-gaap:CapitalLeasesContingentRentalPaymentsDue id="Item-514" contextRef="As_Of_7_12_2014_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember" unitRef="Unit1" decimals="-5">2700000</us-gaap:CapitalLeasesContingentRentalPaymentsDue>
  <us-gaap:CapitalLeasesContingentRentalPaymentsDue id="Item-523" contextRef="As_Of_9_11_2014_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember" unitRef="Unit1" decimals="-5">1400000</us-gaap:CapitalLeasesContingentRentalPaymentsDue>
  <us-gaap:CapitalLeasesContingentRentalPaymentsDue id="Item-517" contextRef="As_Of_4_13_2015_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember" unitRef="Unit1" decimals="-5">400000</us-gaap:CapitalLeasesContingentRentalPaymentsDue>
  <us-gaap:CapitalLeasesContingentRentalPaymentsDue id="Item-448" contextRef="As_Of_10_1_2016_dei_LegalEntityAxis_adus_MeridianLeasingCorporationMember" unitRef="Unit1" decimals="-5">600000</us-gaap:CapitalLeasesContingentRentalPaymentsDue>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDue id="Item-459" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">152000</us-gaap:CapitalLeasesFutureMinimumPaymentsDue>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent id="Item-457" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">67000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears id="Item-458" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">20000</us-gaap:CapitalLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsExecutoryCosts id="Item-460" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">5000</us-gaap:CapitalLeasesFutureMinimumPaymentsExecutoryCosts>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments id="Item-462" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">5000</us-gaap:CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1 id="Item-461" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">147000</us-gaap:CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments id="Item-463" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">142000</us-gaap:CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear id="Item-456" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">65000</us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
  <us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation id="Item-481" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1772000</us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Item-253" contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">8013000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Item-255" contextRef="As_Of_9_30_2017" unitRef="Unit1" decimals="-3">45688000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Item-252" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">53754000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="Item-254" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">147477000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="Item-251" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">37675000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="Item-250" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">93723000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="Item-199" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;9. Commitments and Contingencies&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Legal Proceedings&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company's Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On January 20, 2016, the Company was served with a lawsuit filed in the United States District Court for the Northern District of Illinois against the Company and Cigna Corporation by Stop Illinois Marketing Fraud, LLC, a qui tam relator formed for the purpose of bringing this action. In the action, the plaintiff alleges, inter alia, violations of the federal False Claims Act relating primarily to allegations of violations of the federal Anti-Kickback Statute and&amp;nbsp;allegedly, improper referrals of patients from the Company's home care division to the Company's home health business, substantially all of which was sold in 2013. The plaintiff seeks to recover damages, fees and costs under the federal False Claims Act including treble damages, civil penalties and its attorneys' fees. The U.S. government has declined to intervene at this time. Plaintiff amended its complaint on April 4, 2016 to include additional allegations in support of its False Claims Act claims, including alleged violations of the federal Anti-Kickback Statute. The Company and Cigna Corporation filed a motion to dismiss the amended complaint on June 6, 2016. On February 3, 2017, the Court granted Cigna Corporation's motion to dismiss in full, and granted the Company's motion to dismiss in part, allowing Plaintiff another chance to amend its complaint. Plaintiff timely filed a second amended complaint on March 10, 2017, withdrawing its conspiracy claim under the Federal False Claims Act and adding an explicit claim under the Illinois False Claims Act for the same underlying kickback allegations. On April 7, 2017, the Company filed a partial motion to dismiss the Second Amended Complaint. On May 24, 2017, the State of Illinois filed notice that it was declining to intervene in the plaintiff's claim under the Illinois False Claims Act. On March 21, 2018, the Court granted the Company's motion to dismiss the Second Amended Complaint in part and narrowed the lawsuit to whether the federal False Claims Act was violated with respect to home health services provided at three senior living facilities in Illinois. The Company intends to defend the litigation vigorously and believes the case will not have a material adverse effect on its business, financial condition or results of operations.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Employment Agreements&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company has entered into employment agreements with certain members of senior management. The terms of these agreements are up to&amp;nbsp;&lt;font class="_mt"&gt;four&lt;/font&gt; years with the potential to auto-renew and include non-competition and nondisclosure provisions, as well as provide for defined severance payments in the event of termination.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;A substantial percentage of the Company's workforce is represented by the Service Employees International Union ("SEIU"). The Company has a national agreement with the SEIU. Wages and benefits are negotiated at the local level at various times throughout the year. These negotiations are often initiated when the Company receives increases in hourly rates from various state agencies. Upon expiration of these collective bargaining agreements, the Company may not be able to negotiate labor agreements on satisfactory terms with these labor unions.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Item-192" contextRef="As_Of_12_31_2017" unitRef="Unit17" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Item-734" contextRef="As_Of_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_SecondaryPublicOfferingMember" unitRef="Unit17" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="Item-191" contextRef="As_Of_9_30_2018" unitRef="Unit17" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="Item-194" contextRef="As_Of_12_31_2017" unitRef="Unit16" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="Item-193" contextRef="As_Of_9_30_2018" unitRef="Unit16" decimals="INF">40000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="Item-196" contextRef="As_Of_12_31_2017" unitRef="Unit16" decimals="-3">11632000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="Item-195" contextRef="As_Of_9_30_2018" unitRef="Unit16" decimals="-3">13097000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="Item-198" contextRef="As_Of_12_31_2017" unitRef="Unit16" decimals="-3">11632000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="Item-197" contextRef="As_Of_9_30_2018" unitRef="Unit16" decimals="-3">13097000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue id="Item-150" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">12000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue id="Item-149" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">13000</us-gaap:CommonStockValue>
  <us-gaap:CompensationRelatedCostsPolicyTextBlock id="Item-721" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Workers' Compensation Program&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's workers' compensation insurance program has a $&lt;font class="_mt"&gt;0.4&lt;/font&gt; million deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The Company monitors its claims quarterly and adjusts its reserves accordingly. These costs are recorded primarily as the cost of services on the Company's Unaudited Condensed Consolidated Statements of Income. As of September 30, 2018 and December 31, 2017, the Company recorded $&lt;font class="_mt"&gt;14.8&lt;/font&gt; million and $&lt;font class="_mt"&gt;12.6&lt;/font&gt; million, respectively, in accrued workers' compensation insurance. The accrued workers' compensation insurance is included in accrued expenses on the Company's Unaudited Condensed Consolidated Balance Sheets. As of September 30, 2018 and December 31, 2017, the Company recorded $&lt;font class="_mt"&gt;1.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.5&lt;/font&gt; million, respectively, in workers' compensation insurance recovery receivables. The workers' compensation insurance recovery receivable is included in prepaid expenses and other current assets on the Company's Unaudited Condensed Consolidated Balance Sheets.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
  <us-gaap:ConcentrationRiskDisclosureTextBlock id="Item-583" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;12. Significant Payors&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font size="2" class="_mt"&gt;&lt;strong&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/strong&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;For the three and nine months ended September 30, 2018 and 2017 the Company's revenue&amp;nbsp;by payor type was as follows:&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="88%" colspan="15" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="43%" colspan="6" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="32%" colspan="5" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="21%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 3px;" width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt; &lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;State, local and&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;other&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;governmental&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;programs&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;73,606&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;57.5&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;69,073&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;63.6&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;213,011&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;58.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;% &lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;203,409&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;64.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Managed care&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;organizations&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;45,271&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.3&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;36,866&lt;/font&gt;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;34.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;126,809&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;102,055&lt;/font&gt;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32.5&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Private pay&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,549&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.3&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,959&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,861&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.1&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,230&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Commercial&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;insurance&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,869&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.5&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;694&lt;/font&gt;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.6&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,271&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.2&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,064&lt;/font&gt;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.7&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,799&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.4&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,654&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total personal&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;care segment&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;net service&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;128,094&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;362,606&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;% &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;"&gt; &lt;/font&gt;

&lt;p class="MetaData" style="margin: 0px;"&gt;&lt;font size="2" class="_mt"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;&lt;a name="page_24"&gt; &lt;/a&gt;&lt;/div&gt;

&lt;div&gt;&amp;nbsp;&lt;/div&gt;

&lt;div&gt;&amp;nbsp;&lt;/div&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div align="left"&gt;&lt;br /&gt;&amp;nbsp;&lt;br /&gt;&amp;nbsp;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Medicare&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,677&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;93.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,030&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;93.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Managed care organizations&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;426&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6.0&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;721&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6.1&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.2&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.1&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total hospice segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,765&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="9"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Medicare&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,184&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;90.2&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,588&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;91.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Managed care organizations&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;221&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;9.1&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;329&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;8.3&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;27&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total home health segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; The percentages of segment revenue for each of the Company's significant states for the three and nine months ended September 30, 2018 and 2017 were as follows:&lt;/font&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="6%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="4" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="5" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 2px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Illinois&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 16px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;58,863&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;46.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;56,813&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;52.3&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" colspan="2" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;174,457&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;48.2&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;165,370&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;52.7&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New York&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,814&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.1&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,904&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.7&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;47,999&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.2&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;43,562&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.9&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Mexico&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,013&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12.5&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10,645&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;9.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" colspan="2" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;42,594&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,854&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7.9&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;All other&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;states&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;36,404&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;28.4&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;26,230&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24.2&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;97,556&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;26.9&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;79,972&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;25.5&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;personal&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;care&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;segment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;net&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;service&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;revenues $&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;128,094&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" colspan="2" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;362,606&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="14"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div&gt;

&lt;div align="left"&gt;&amp;nbsp;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div align="left"&gt;&amp;nbsp;&lt;/div&gt;&lt;/div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div align="left"&gt;&amp;nbsp;&lt;/div&gt;

&lt;div&gt;

&lt;p style="margin: 0px;"&gt; &lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="37%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="16%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="12%"&gt; &lt;/td&gt;
&lt;td width="14%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="63%" colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New Mexico&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 9px;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,765&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total hospice segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 9px;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,765&lt;/font&gt;&lt;/td&gt;
&lt;td width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;
&lt;td&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="63%" colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended&lt;/font&gt;&lt;/b&gt; &lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt; &lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt; &lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt; &lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New Mexico&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 9px;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total home health segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 9px;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;A substantial portion of the Company's net service revenues and accounts receivable are derived from services performed for state and local governmental agencies. The Illinois Department on Aging, the largest payor program for our Illinois personal care operations, accounted for &lt;font class="_mt"&gt;29.5&lt;/font&gt;% and &lt;font class="_mt"&gt;36.6&lt;/font&gt;% of the Company's net service revenues for the three months ended September 30, 2018 and 2017, respectively and accounted for &lt;font class="_mt"&gt;31.8&lt;/font&gt;% and &lt;font class="_mt"&gt;36.6&lt;/font&gt;% of the Company's net service revenues for the nine months ended September 30, 2018 and 2017, respectively.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;div class="MetaData"&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The related receivables due from the Illinois Department on Aging represented &lt;font class="_mt"&gt;27.4&lt;/font&gt;% and &lt;font class="_mt"&gt;37.5&lt;/font&gt;% of the Company's net accounts receivable at September 30, 2018 and December 31, 2017, respectively&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-541" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember" unitRef="Unit12" decimals="3">0.366</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-677" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-581" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-573" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.255</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-549" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.527</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-565" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.079</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-557" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.139</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-665" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.007</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-649" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.325</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-657" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.020</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-641" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.648</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-582" contextRef="Duration_1_1_2017_To_12_31_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember" unitRef="Unit12" decimals="3">0.375</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-585" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember" unitRef="Unit12" decimals="3">0.366</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-673" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-577" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-569" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.242</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-545" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.523</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-561" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.098</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-553" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.137</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-661" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.006</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-645" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.340</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-653" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.018</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-637" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.636</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-584" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_AccountsReceivableMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember" unitRef="Unit12" decimals="3">0.274</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-679" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember" unitRef="Unit12" decimals="3">0.318</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-625" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-609" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-675" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-593" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-633" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-579" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-571" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.269</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-547" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.482</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-589" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-629" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-563" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.117</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-555" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.132</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-663" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.012</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-617" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">0.083</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-601" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">0.061</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-647" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.350</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-613" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">0.910</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-597" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">0.938</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-621" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">0.007</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-605" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">0.001</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-669" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.010</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-655" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.041</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-639" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.587</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-678" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_adus_IllinoisDepartmentOnAgingMember" unitRef="Unit12" decimals="3">0.295</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-623" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-607" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-671" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-591" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-631" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-575" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-567" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.284</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-543" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.460</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-587" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-627" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">1.000</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-559" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.125</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-551" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.131</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-659" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.015</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-615" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">0.091</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-599" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">0.060</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-643" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.353</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-611" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">0.902</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-595" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">0.938</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-619" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit12" decimals="3">0.007</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-603" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit12" decimals="3">0.002</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-667" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.014</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-651" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.043</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 id="Item-635" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit12" decimals="3">0.575</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConsolidationPolicyTextBlock id="Item-540" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Principles of Consolidation&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;These unaudited condensed consolidated financial statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company used the cost method to account for its investment in joint ventures in which it owned 10% equity interests. The Company sold such investments on October 1, 2017. See Note 3 "Gain on Sale of Assets" for additional information.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-855" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">228877000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-854" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">228877000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-843" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">79539000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-842" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">79539000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-795" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">277985000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-794" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2819000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-793" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">6351000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-792" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">268815000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-772" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">100926000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-771" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">1721000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-770" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">3777000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold id="Item-769" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">95428000</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-468" contextRef="Duration_10_30_2018_To_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_FederalFundsRateMember" unitRef="Unit12" decimals="4">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-513" contextRef="Duration_10_30_2018_To_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember" unitRef="Unit12" decimals="4">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-455" contextRef="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-445" contextRef="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-529" contextRef="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-471" contextRef="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-446" contextRef="Duration_10_30_2018_To_10_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember" unitRef="Unit12" decimals="4">0.0000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-519" contextRef="Duration_10_31_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_FederalFundsRateMember" unitRef="Unit12" decimals="4">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-520" contextRef="Duration_10_31_2018_To_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember" unitRef="Unit12" decimals="4">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-530" contextRef="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-489" contextRef="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-488" contextRef="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-452" contextRef="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_StatementScenarioAxis_adus_BasedOnApplicableSeniorLeverageRatioMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit12" decimals="4">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 id="Item-522" contextRef="Duration_10_31_2018_To_10_31_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember_us-gaap_VariableRateAxis_adus_OneMonthLiborMember" unitRef="Unit12" decimals="4">0.0000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
  <us-gaap:DebtInstrumentCarryingAmount id="Item-500" contextRef="As_Of_12_31_2017_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember" unitRef="Unit1" decimals="-3">1002000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount id="Item-498" contextRef="As_Of_12_31_2017_us-gaap_DebtInstrumentAxis_adus_SeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember" unitRef="Unit1" decimals="-3">44438000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount id="Item-499" contextRef="As_Of_9_30_2018_us-gaap_LongtermDebtTypeAxis_us-gaap_CapitalLeaseObligationsMember" unitRef="Unit1" decimals="-3">142000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount id="Item-497" contextRef="As_Of_9_30_2018_us-gaap_DebtInstrumentAxis_adus_SeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember" unitRef="Unit1" decimals="-3">103170000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentFeeAmount id="Item-444" contextRef="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">2900000</us-gaap:DebtInstrumentFeeAmount>
  <us-gaap:DebtInstrumentFeeAmount id="Item-472" contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">1100000</us-gaap:DebtInstrumentFeeAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Item-527" contextRef="As_Of_10_1_2016_dei_LegalEntityAxis_adus_MeridianLeasingCorporationMember" unitRef="Unit12" decimals="INF">0.111</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Item-491" contextRef="As_Of_12_31_2017_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember" unitRef="Unit12" decimals="INF">0.0386</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Item-524" contextRef="As_Of_5_1_2018_dei_LegalEntityAxis_adus_FordMotorCreditCompanyLlcMember" unitRef="Unit12" decimals="INF">0.0688</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Item-450" contextRef="As_Of_9_30_2018_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember_srt_RangeAxis_srt_MaximumMember" unitRef="Unit12" decimals="INF">0.036</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Item-469" contextRef="As_Of_9_30_2018_dei_LegalEntityAxis_adus_FirstAmericanCommercialBancorpMember_srt_RangeAxis_srt_MinimumMember" unitRef="Unit12" decimals="INF">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage id="Item-511" contextRef="As_Of_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember" unitRef="Unit12" decimals="INF">0.046</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentMaturityDate id="Item-487" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember">2020-11-10</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentMaturityDate id="Item-447" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_AmendedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember">2019-01-31</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentMaturityDate id="Item-451" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember">2022-05-08</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtInstrumentMaturityDate id="Item-509" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember">2023-05-08</us-gaap:DebtInstrumentMaturityDate>
  <us-gaap:DebtPolicyTextBlock id="Item-743" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Debt Issuance Costs&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method. The Company has classified the debt issuance costs as current portion of long-term debt or long-term debt, less current portion as of September 30, 2018 and December 31, 2017.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
  <us-gaap:DeferredFinanceCostsNet id="Item-502" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">2481000</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:DeferredFinanceCostsNet id="Item-501" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">2103000</us-gaap:DeferredFinanceCostsNet>
  <us-gaap:DeferredIncomeTaxExpenseBenefit id="Item-206" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">397000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <us-gaap:DeferredTaxAssetsNetNoncurrent id="Item-126" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">1601000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:DeferredTaxLiabilitiesGrossNoncurrent id="Item-142" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1098000</us-gaap:DeferredTaxLiabilitiesGrossNoncurrent>
  <us-gaap:DepreciationAndAmortization id="Item-818" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">4811000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="Item-817" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">1781000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="Item-832" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">6676000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationAndAmortization id="Item-831" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">2535000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Item-205" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">4811000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization id="Item-204" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">6676000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:EarningsPerShareBasic id="Item-429" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit17" decimals="2">0.90</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic id="Item-427" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit17" decimals="2">0.30</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic id="Item-428" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit17" decimals="2">1.08</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic id="Item-426" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit17" decimals="2">0.29</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted id="Item-433" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit17" decimals="2">0.89</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted id="Item-431" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit17" decimals="2">0.29</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted id="Item-432" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit17" decimals="2">1.06</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted id="Item-430" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit17" decimals="2">0.28</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerSharePolicyTextBlock id="Item-711" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Diluted Net Income Per Common Share&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company's outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Included in the Company's calculation of diluted earnings per share for the three and nine months ended September 30, 2018 were approximately&amp;nbsp;&lt;font class="_mt"&gt;708,000&lt;/font&gt; stock options outstanding, of which approximately&amp;nbsp;&lt;font class="_mt"&gt;307,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;213,000&lt;/font&gt; respectively, were dilutive. In addition, there were approximately&amp;nbsp;&lt;font class="_mt"&gt;148,000&lt;/font&gt; restricted stock awards outstanding&amp;nbsp;&lt;font class="_mt"&gt;83,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;83,000&lt;/font&gt; of which were dilutive for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Included in the Company's calculation of diluted earnings per share for the three and nine months ended September 30, 2017 were approximately&amp;nbsp;&lt;font class="_mt"&gt;479,000&lt;/font&gt; stock options outstanding, of which approximately&amp;nbsp;&lt;font class="_mt"&gt;102,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;102,000&lt;/font&gt; respectively, were dilutive. In addition, there were approximately&amp;nbsp;&lt;font class="_mt"&gt;148,000&lt;/font&gt; restricted stock awards outstanding&amp;nbsp;&lt;font class="_mt"&gt;43,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;50,000&lt;/font&gt; of which were dilutive for the three and nine months ended September 30, 2017, respectively.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="Item-364" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.321</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="Item-366" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.322</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="Item-363" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.206</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="Item-351" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.207</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Item-354" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Item-365" contextRef="Duration_1_1_2017_To_12_31_2017" unitRef="Unit12" decimals="3">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Item-343" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.350</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Item-353" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="Item-342" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense id="Item-360" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense id="Item-349" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense id="Item-359" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense id="Item-348" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments id="Item-362" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments id="Item-361" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.009</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments id="Item-350" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Item-356" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.049</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Item-345" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit12" decimals="3">0.044</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Item-355" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.065</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes id="Item-344" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit12" decimals="3">0.053</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
  <us-gaap:FairValueOfFinancialInstrumentsPolicy id="Item-728" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Fair Value Measurements&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported on the Company's Unaudited Condensed Consolidated Balance Sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company's long-term debt with variable interest rates approximates fair value based on instruments with similar terms using level 2 inputs as defined under ASC Topic 820 &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Fair Value Measurement&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill, if required, and indefinite-lived intangible assets and also when determining the fair value of contingent consideration, if applicable. To determine the fair value in these situations, the Company uses Level 3 inputs, under ASC Topic 820 and defined as unobservable inputs in which little or no market data exists; therefore requiring an entity to develop its own assumptions, such as discounted cash flows, or if available, what a market participant would pay on the measurement date.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company uses various valuation techniques to determine fair value of its intangible assets, including relief-from-royalty, income approach, discounted cash flow analysis, and multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about future market growth and trends, forecasted revenue and costs, expected periods over which the assets will be utilized, appropriate discount rates and other variables.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-300" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">39217000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization xsi:nil="true" id="Item-299" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember" unitRef="Unit1" />
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-296" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="Unit1" decimals="-3">29147000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-298" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="Unit1" decimals="-3">1872000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-297" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="Unit1" decimals="-3">8198000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-319" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">44128000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-318" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember" unitRef="Unit1" decimals="-3">101000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-315" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="Unit1" decimals="-3">32131000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-317" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="Unit1" decimals="-3">1954000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization id="Item-316" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="Unit1" decimals="-3">9942000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="Item-731" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife id="Item-718" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:GainLossOnSaleOfBusiness id="Item-816" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">2065000</us-gaap:GainLossOnSaleOfBusiness>
  <us-gaap:GainLossOnSaleOfBusiness id="Item-275" contextRef="Duration_3_1_2017_To_3_1_2017_srt_StatementGeographicalAxis_stpr_IL" unitRef="Unit1" decimals="-5">2100000</us-gaap:GainLossOnSaleOfBusiness>
  <us-gaap:GainLossOnSaleOfEquityInvestments id="Item-277" contextRef="Duration_10_1_2017_To_10_1_2017_dei_LegalEntityAxis_adus_LhcGroupIncMember" unitRef="Unit1" decimals="-5">400000</us-gaap:GainLossOnSaleOfEquityInvestments>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-382" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">57239000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-861" contextRef="Duration_1_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">24129000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-860" contextRef="Duration_1_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">24129000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-380" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">19359000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-849" contextRef="Duration_7_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">7957000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-848" contextRef="Duration_7_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">7957000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-381" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">76084000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-807" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">32345000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-806" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">946000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-805" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">2326000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-804" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">29073000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-379" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">28218000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-783" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">12524000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-782" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">604000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-781" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">1474000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="Item-780" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">10446000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:Goodwill id="Item-36" contextRef="As_Of_8_1_2017_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-3">16671000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-5" contextRef="As_Of_10_1_2017_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-3">1089000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-327" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">90339000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-326" contextRef="As_Of_12_31_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">90339000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-19" contextRef="As_Of_1_1_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-3">2751000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-79" contextRef="As_Of_4_1_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-3">12389000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-60" contextRef="As_Of_5_1_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-3">28082000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-335" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">134063000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-57" contextRef="As_Of_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AffiliateBranchesOfArcadiaMember" unitRef="Unit1" decimals="-5">600000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-334" contextRef="As_Of_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2499000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-333" contextRef="As_Of_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">19040000</us-gaap:Goodwill>
  <us-gaap:Goodwill id="Item-332" contextRef="As_Of_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">112524000</us-gaap:Goodwill>
  <us-gaap:GoodwillAcquiredDuringPeriod id="Item-331" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">43724000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAcquiredDuringPeriod id="Item-330" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2499000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAcquiredDuringPeriod id="Item-329" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">19040000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAcquiredDuringPeriod id="Item-328" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">22185000</us-gaap:GoodwillAcquiredDuringPeriod>
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock id="Item-283" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;5. Goodwill and Intangible Assets&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;A summary of the goodwill activity for the nine months ended September 30, 2018 is provided below:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="38%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="24%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Goodwill&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 1px;" colspan="3" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill as of December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;90,339&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 1px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;90,339&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Additions for acquisitions&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;22,185&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;19,040&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,499&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;43,724&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill as of September 30, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;112,524&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;19,040&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,499&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;134,063&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from&amp;nbsp;&lt;font class="_mt"&gt;two&lt;/font&gt; to&amp;nbsp;&lt;font class="_mt"&gt;twenty-five&lt;/font&gt; years.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following as of September 30, 2018 and December 31, 2017:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="29%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Customer&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Trade&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;and referral&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;names and&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Non-competition&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;State&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;relationships&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;trademarks&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;agreements&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Licenses&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross balance at December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;39,017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,641&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,155&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;55,813&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accumulated amortization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(29,147&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(8,198&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,872&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(39,217&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net balance at December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;9,870&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,443&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;283&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,596&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross balance at January 1, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;39,017&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,641&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,155&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;55,813&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Additions for acquisitions&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,209&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,927&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,376&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,512&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accumulated amortization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(32,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(9,942&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,954&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(101&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(44,128&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net balance at September 30, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,095&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,626&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;201&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,275&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;26,197&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Amortization expense related to the identifiable intangible assets amounted to $&lt;font class="_mt"&gt;1.9&lt;/font&gt; million and $&lt;font class="_mt"&gt;4.9&lt;/font&gt; million for the three and nine months ended September 30, 2018, respectively, and $&lt;font class="_mt"&gt;1.2&lt;/font&gt; million and $&lt;font class="_mt"&gt;3.3&lt;/font&gt; million for the three and nine months ended September 30, 2017, respectively. Goodwill is not amortized pursuant to ASC Topic 350.&lt;/font&gt;&lt;/p&gt; &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy id="Item-730" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's carrying value of goodwill is the excess of the purchase price over the fair value of the net assets acquired from various acquisitions. In accordance with ASC Topic 350, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill and Other Intangible Assets&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. The Company may use a qualitative test, known as "Step 0," or a &lt;font class="_mt"&gt;two&lt;/font&gt;-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two-step analysis. In 2017, the Company elected to implement Step 0 and was not required to conduct the remaining two-step analysis. The results of the Company's Step 0 assessments indicated that it was more likely than not that the fair value of its reporting unit exceeded its carrying value and therefore the Company concluded that there were&amp;nbsp;&lt;font class="_mt"&gt;no&lt;/font&gt; impairments for the year ended December 31, 2017.&amp;nbsp;&lt;font class="_mt"&gt;No&lt;/font&gt; impairment charges were recorded for the three and nine months ended September 30, 2018 or 2017.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
  <us-gaap:GoodwillImpairmentLoss id="Item-702" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:GoodwillImpairmentLoss id="Item-720" contextRef="Duration_1_1_2017_To_12_31_2017" unitRef="Unit1" decimals="-5">0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:GoodwillImpairmentLoss id="Item-704" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:GoodwillImpairmentLoss id="Item-703" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:GoodwillImpairmentLoss id="Item-701" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">0</us-gaap:GoodwillImpairmentLoss>
  <us-gaap:GrossProfit id="Item-857" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">84881000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-856" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">84881000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-845" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">29053000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-844" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">29053000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-799" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">100330000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-798" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">1125000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-797" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">5414000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-796" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">93791000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-776" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">36705000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-775" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">700000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-774" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">3339000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="Item-773" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">32666000</us-gaap:GrossProfit>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="Item-705" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="Item-707" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="Item-706" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:ImpairmentOfIntangibleAssetsFinitelived id="Item-708" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="Item-826" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">15274000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="Item-825" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">5031000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="Item-838" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">15988000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments id="Item-837" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">4473000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:IncomeTaxDisclosureTextBlock id="Item-336" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;8. Income Taxes&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;A reconciliation of the statutory federal tax rate of 21.0% for the three and nine months ended September 30, 2018 and 35.0% for the three and nine months ended September 30, 2017 is summarized as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="51%"&gt; &lt;/td&gt;
&lt;td width="26%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="14%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Federal income tax at statutory rate&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;21.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;State and local taxes, net of federal benefit&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5.3&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.4&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Jobs tax credits, net&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(10.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(7.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Nondeductible permanent items&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2.0&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2.4&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective income tax rate&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;20.7&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32.2&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="5"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Federal income tax at statutory rate&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;21.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;State and local taxes, net of federal benefit&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.9&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Jobs tax credits, net&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(9.3&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(7.5&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Nondeductible permanent items&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(0.8&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective income tax rate&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;20.6&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32.1&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act ("Tax Reform Act"). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates. The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of &lt;font class="_mt"&gt;35.0&lt;/font&gt;% to a flat &lt;font class="_mt"&gt;21.0&lt;/font&gt;% rate, effective January 1, 2018. The effective income tax rate was &lt;font class="_mt"&gt;20.7&lt;/font&gt;% and &lt;font class="_mt"&gt;32.2&lt;/font&gt;% for the three months ended September 30, 2018 and 2017, respectively. The difference between our federal statutory and effective income tax rates are principally due to the inclusion of state taxes and the use of federal employment tax credits. A provisional valuation allowance increased $&lt;font class="_mt"&gt;0.2&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.4&lt;/font&gt; million in the three and nine months ended September 30, 2018, respectively, as a result of the elimination of a performance based equity exception in calculating the $1.0 million limitation for 162(m) under the Tax Reform Act.&lt;/font&gt;&lt;/p&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In December 2017, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Income Tax Accounting Implications of the Tax Cuts and Job Act&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, ("SAB 118") to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared, or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the Tax Reform Act. Additional work is necessary for a more detailed analysis of our deferred tax assets and liabilities as well as potential correlative adjustments. During the measurement period, impacts of the law are expected to be recorded at the time a reasonable estimate for all or a portion of the effects can be made and provisional amounts can be recognized and adjusted as information becomes available, prepared or analyzed. No additional estimated amounts were finalized during the quarter ending September 30, 2018.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font size="2" class="_mt"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font size="2" class="_mt"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font size="2" class="_mt"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font size="2" class="_mt"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt; &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncomeTaxesPaidNet id="Item-259" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">5357000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:IncomeTaxesPaidNet id="Item-258" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">4234000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:IncomeTaxExpenseBenefit id="Item-421" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">4908000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="Item-419" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">1623000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="Item-420" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">3287000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit id="Item-418" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">927000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxPolicyTextBlock id="Item-756" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Income Tax Expense&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company accounts for income taxes under the provisions of ASC Topic 740, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Income Taxes. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company's assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. ASC Topic 740 also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="Item-221" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">418000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="Item-220" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">1844000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="Item-217" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">-15451000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="Item-216" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">5284000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="Item-223" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">3750000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccruedLiabilities id="Item-222" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">2713000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Item-219" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">281000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="Item-218" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">-2007000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IntangibleAssetsFiniteLivedPolicy id="Item-699" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Intangible Assets&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from&amp;nbsp;&lt;font class="_mt"&gt;two&lt;/font&gt; to&amp;nbsp;&lt;font class="_mt"&gt;twenty-five&lt;/font&gt; years.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Intangible assets with finite lives are amortized using the estimated economic benefit method over the useful life and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company would recognize an impairment loss when the estimated future non-discounted cash flows associated with the intangible asset is less than the carrying value. An impairment charge would then be recorded for the excess of the carrying value over the fair value.&amp;nbsp;&lt;font class="_mt"&gt;No&lt;/font&gt; impairment charge was recorded for the three and nine months ended September 30, 2018 and 2017.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company uses various valuation techniques to determine fair value of its intangible assets, including relief-from-royalty, income approach, discounted cash flow analysis, and multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about future market growth and trends, forecasted revenue and costs, expected periods over which the assets will be utilized, appropriate discount rates and other variables. The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-295" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">55813000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill xsi:nil="true" id="Item-294" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember" unitRef="Unit1" />
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-291" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="Unit1" decimals="-3">39017000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-293" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="Unit1" decimals="-3">2155000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-292" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="Unit1" decimals="-3">14641000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-310" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">55813000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill xsi:nil="true" id="Item-309" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember" unitRef="Unit1" />
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-306" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="Unit1" decimals="-3">39017000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-308" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="Unit1" decimals="-3">2155000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill id="Item-307" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="Unit1" decimals="-3">14641000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-305" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">16596000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill xsi:nil="true" id="Item-304" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember" unitRef="Unit1" />
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-301" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="Unit1" decimals="-3">9870000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-303" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="Unit1" decimals="-3">283000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-302" contextRef="As_Of_12_31_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="Unit1" decimals="-3">6443000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-324" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">26197000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-323" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_adus_StateLicensesMember" unitRef="Unit1" decimals="-3">2275000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-320" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" unitRef="Unit1" decimals="-3">12095000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-322" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" unitRef="Unit1" decimals="-3">201000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill id="Item-321" contextRef="As_Of_9_30_2018_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksAndTradeNamesMember" unitRef="Unit1" decimals="-3">11626000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:InterestExpense id="Item-822" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">3629000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="Item-821" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">870000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="Item-836" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">3836000</us-gaap:InterestExpense>
  <us-gaap:InterestExpense id="Item-835" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">1543000</us-gaap:InterestExpense>
  <us-gaap:InterestExpensePolicyTextBlock id="Item-722" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Interest Expense&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's interest expense consists of interest and unused credit line fees on its credit facilities, interest on its capital lease obligations, and amortization and write-off of debt issuance costs, which is reported in the statement of income when incurred.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:InterestExpensePolicyTextBlock>
  <us-gaap:InterestIncomeExpenseNet id="Item-411" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">-3579000</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="Item-409" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">-840000</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="Item-410" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">-1368000</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeExpenseNet id="Item-408" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">-1430000</us-gaap:InterestIncomeExpenseNet>
  <us-gaap:InterestIncomeOther id="Item-753" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">0</us-gaap:InterestIncomeOther>
  <us-gaap:InterestIncomeOther id="Item-752" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">0</us-gaap:InterestIncomeOther>
  <us-gaap:InterestIncomeOther id="Item-727" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">2300000</us-gaap:InterestIncomeOther>
  <us-gaap:InterestPaidNet id="Item-257" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">1538000</us-gaap:InterestPaidNet>
  <us-gaap:InterestPaidNet id="Item-256" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">3202000</us-gaap:InterestPaidNet>
  <us-gaap:InvestmentIncomeInterest id="Item-820" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">50000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest id="Item-819" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">30000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest id="Item-834" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">2468000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:InvestmentIncomeInterest id="Item-833" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">113000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:Liabilities id="Item-148" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">92030000</us-gaap:Liabilities>
  <us-gaap:Liabilities id="Item-147" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">162968000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Item-158" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">267110000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="Item-157" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">430778000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent id="Item-139" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">51724000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="Item-138" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">62338000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesNoncurrent id="Item-146" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">40306000</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="Item-145" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">100630000</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LineOfCredit id="Item-516" contextRef="As_Of_12_31_2017_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember" unitRef="Unit1" decimals="-5">44400000</us-gaap:LineOfCredit>
  <us-gaap:LineOfCredit id="Item-466" contextRef="As_Of_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember" unitRef="Unit1" decimals="-5">103200000</us-gaap:LineOfCredit>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-495" contextRef="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember" unitRef="Unit1" decimals="-5">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-454" contextRef="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_adus_UncommittedIncrementalTermLoanMember" unitRef="Unit1" decimals="-5">50000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-494" contextRef="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LetterOfCreditMember" unitRef="Unit1" decimals="-5">35000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-490" contextRef="As_Of_5_7_2017_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="Unit1" decimals="-5">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-525" contextRef="As_Of_12_31_2017_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="Unit1" decimals="-5">105100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-449" contextRef="As_Of_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="Unit1" decimals="-5">88600000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-528" contextRef="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-484" contextRef="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_TerminatedSeniorSecuredCreditFacilityMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">125000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-526" contextRef="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">80000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-453" contextRef="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_TermLoanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">45000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-486" contextRef="As_Of_10_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">125000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-485" contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">269600000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-531" contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">19600000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity id="Item-467" contextRef="As_Of_10_31_2018_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" unitRef="Unit1" decimals="-5">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
  <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage id="Item-473" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="Unit12" decimals="4">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
  <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage id="Item-493" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_DebtInstrumentAxis_adus_NewCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_us-gaap_RevolvingCreditFacilityMember" unitRef="Unit12" decimals="4">0.0020</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
  <us-gaap:LongTermDebt id="Item-504" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">42959000</us-gaap:LongTermDebt>
  <us-gaap:LongTermDebt id="Item-503" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">101209000</us-gaap:LongTermDebt>
  <us-gaap:LongTermDebtCurrent id="Item-506" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">3099000</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtCurrent id="Item-505" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">2318000</us-gaap:LongTermDebtCurrent>
  <us-gaap:LongTermDebtNoncurrent id="Item-508" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">39860000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtNoncurrent id="Item-507" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">98891000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:LongTermDebtTextBlock id="Item-442" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;7. Long-Term Debt&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Long-term debt consisted of the following:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="43%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="17%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;
&lt;td width="17%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;December 31, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Term loan under the credit facility&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;103,170&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;44,438&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Capital leases&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;142&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,002&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less unamortized issuance costs&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,103&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,481&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;101,209&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;42,959&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less current maturities&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,318&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(3,099&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Long-term debt&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;98,891&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;39,860&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Capital Leases&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On May 1, 2018, with the acquisition of Ambercare, the Company acquired the remainder of a capital lease with Ford Motor Credit Company LLC. The &lt;font class="_mt"&gt;48&lt;/font&gt;-month capital lease was originally entered into on June 27, 2016. The underlying assets are included in "Property and equipment, net of accumulated depreciation and amortization" in the accompanying Unaudited Condensed Consolidated Balance Sheets. This capital lease obligation requires monthly payments through August 2020 and has an implicit interest rate of &lt;font class="_mt"&gt;6.88%&lt;/font&gt;.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On July 12, 2014, September 11, 2014 and April 13, 2015, the Company executed&amp;nbsp;&lt;font class="_mt"&gt;three&lt;/font&gt; &lt;font class="_mt"&gt;48&lt;/font&gt;-month capital lease agreements for $&lt;font class="_mt"&gt;2.7&lt;/font&gt; million, $&lt;font class="_mt"&gt;1.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.4&lt;/font&gt; million, respectively, with First American Commercial Bancorp, Inc. The capital leases were entered into to finance property and equipment at the Company's support center in Downers Grove, IL. The underlying assets are included in "Property and equipment, net of accumulated depreciation and amortization" in the accompanying Unaudited Condensed Consolidated Balance Sheets. These capital lease obligations require monthly payments through September 2019 and have implicit interest rates that range from &lt;font class="_mt"&gt;3.0&lt;/font&gt;% to &lt;font class="_mt"&gt;3.6&lt;/font&gt;%. At the end of the term, the Company has the option to purchase the assets for $1 per lease agreement.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective October 1, 2016, the Company entered into a &lt;font class="_mt"&gt;25&lt;/font&gt;-month capital lease agreement for $&lt;font class="_mt"&gt;0.6&lt;/font&gt; million with Meridian Leasing Corporation. The capital lease was entered into to finance property and equipment for the Company's telephone system. The underlying assets are included in "Property and equipment, net of accumulated depreciation and amortization" in the accompanying Unaudited Condensed Consolidated Balance Sheets. This capital lease obligation requires monthly payments through October 2018 and has an implicit interest rate of &lt;font class="_mt"&gt;11.1&lt;/font&gt;%. At the end of the term, the Company has the option to purchase the assets for $1 per lease agreement.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;An analysis of the leased property under capital leases by major classes is as follows.&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="51%"&gt; &lt;/td&gt;
&lt;td width="18%"&gt; &lt;/td&gt;
&lt;td width="26%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Asset Balances at&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Classes of Property&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,484&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;868&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;635&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer software&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;303&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Transportation equipment&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;107&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,397&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less: accumulated depreciation and amortization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,772&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,625&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: center;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;&lt;a name="page_19"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The future minimum payments for capital leases as of September 30, 2018 are as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="59%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="21%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 1px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Capital Lease&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 2px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts In&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2018&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;65&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2019&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;67&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2020&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;20&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;152&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less: amount representing estimated executory&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;costs (such as taxes, maintenance and&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;insurance), including profit thereon,&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;included in total minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(5&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;147&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less: amount representing interest&lt;/font&gt;&lt;sup&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1)&lt;/font&gt;&lt;/sup&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(5&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Present value of net minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;(2&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;142&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table class="MetaData" cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td valign="top" width="2%"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1)&lt;/font&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &lt;/td&gt;
&lt;td class="MetaData" width="98%"&gt;

&lt;div&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Amount necessary to reduce net minimum lease payments to present value calculated at the Company's incremental borrowing rate at lease inception.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top" width="2%"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2)&lt;/font&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &lt;/td&gt;
&lt;td class="MetaData" width="98%"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Included in the balance sheet as $&lt;font class="_mt"&gt;114,000&lt;/font&gt; of the current portion of long-term debt and $&lt;font class="_mt"&gt;28,000&lt;/font&gt; of the long-term debt, less current portion.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Amended and Restated Senior Secured Credit Facility&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On October 31, 2018, the Company amended and restated its existing Credit Agreement (the "New Credit Agreement") with certain lenders and Capital One, National Association as a lender and swing line lender and as agent for all lenders. This amended and restated credit facility totals $&lt;font class="_mt"&gt;269.6&lt;/font&gt; million, inclusive of a $&lt;font class="_mt"&gt;250.0&lt;/font&gt; million revolving loan and a $&lt;font class="_mt"&gt;19.6&lt;/font&gt; million delayed draw term loan, and amends and restates the Company's previous senior secured credit facility totaling $&lt;font class="_mt"&gt;250.0&lt;/font&gt; million. The maturity of this amended and restated credit facility is &lt;font class="_mt"&gt;May 8, 2023&lt;/font&gt;, with borrowing under the delayed draw term loan available until &lt;font class="_mt"&gt;January 31, 2019&lt;/font&gt;. Interest on the Company's amended and restated credit facility may be payable at (x) the sum of (i) an applicable margin ranging from &lt;font class="_mt"&gt;0.75&lt;/font&gt;% to &lt;font class="_mt"&gt;1.50&lt;/font&gt;% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the "prime rate," (b) the sum of the federal funds rate plus a margin of &lt;font class="_mt"&gt;0.50&lt;/font&gt;% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than &lt;font class="_mt"&gt;0.00&lt;/font&gt;%) plus a margin of &lt;font class="_mt"&gt;1.00&lt;/font&gt;% or (y) the sum of (i) an applicable margin ranging from &lt;font class="_mt"&gt;1.75&lt;/font&gt;% to &lt;font class="_mt"&gt;2.50&lt;/font&gt;% based on the applicable senior net leverage ratio plus (ii) the offered rate per annum for similar dollar deposits for the applicable interest period that appears on Reuters Screen LIBOR01 page (not to be less than zero). Swing loans may not be LIBOR loans. The availability of additional draws under this amended and restated credit facility is conditioned, among other things, upon (after giving effect to such draws) the&amp;nbsp;Total Net&amp;nbsp;Leverage Ratio (as defined in the New Credit Agreement)&amp;nbsp;not exceeding &lt;font class="_mt"&gt;3.75&lt;/font&gt;:1.00. In certain circumstances, in connection with a Material&amp;nbsp;Acquisition (as defined in the New Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to &lt;font class="_mt"&gt;4.25&lt;/font&gt;:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters. In connection with this amended and restated credit facility, the Company incurred approximately&amp;nbsp;&lt;font class="_mt"&gt;$1.1&lt;/font&gt; million of debt issuance costs.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Addus HealthCare, Inc. ("Addus HealthCare") is the borrower, and its parent, Holdings, and substantially all of Holdings' subsidiaries are guarantors under this amended and restated credit facility, and it is secured by a first priority security interest in all of the Company's and the other credit parties' current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The New Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company pays a fee ranging from &lt;font class="_mt"&gt;0.20&lt;/font&gt;% to &lt;font class="_mt"&gt;0.35&lt;/font&gt;% based on the applicable senior net leverage ratio times the unused portion of the revolving portion of the amended and restated credit facility.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The New Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The New Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the New Credit Agreement), a &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;requirement to stay below a maximum Total Net Leverage Ratio (as defined in the New Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $&lt;font class="_mt"&gt;7.5&lt;/font&gt; million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) subject to compliance with the Total Net Leverage Ratio (as defined in the New Credit Agreement), restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Senior Secured Credit Facility&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prior to October 31, 2018, the Company was party to a credit agreement (the "Credit Agreement") with certain lenders and Capital One, N.A., as a lender and swing lender and as agent for all lenders. This credit facility totaled $&lt;font class="_mt"&gt;250.0&lt;/font&gt; million, replaced the Company's previous senior secured credit facility totaling $&lt;font class="_mt"&gt;125.0&lt;/font&gt; million ("Terminated Senior Secured Credit Facility", see description below for more details), and terminated the Second Amended and Restated Credit and Guaranty Agreement, dated as of November 10, 2015, as modified by the May 24, 2016 amendment (as amended, the "Terminated Senior Secured Credit Agreement"), between the Company, certain lenders and Fifth Third Bank, as agent, which evidenced the Terminated Senior Secured Credit Facility. The credit facility included a $&lt;font class="_mt"&gt;125.0&lt;/font&gt; million revolving loan, a $&lt;font class="_mt"&gt;45.0&lt;/font&gt; million term loan and an $&lt;font class="_mt"&gt;80.0&lt;/font&gt; million delayed draw term loan. The credit facility was to mature on &lt;font class="_mt"&gt;May 8, 2022&lt;/font&gt;. Addus HealthCare was the borrower, with its parent, Holdings, and substantially all of Holdings' subsidiaries being guarantors under the credit facility. The credit facility was secured by a first priority security interest in all of the Company's and the other credit parties' current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The availability of additional draws under the revolving credit portion of the Company's credit facility was conditioned, among other things, upon (after giving effect to such draws) the ratio of Consolidated Total Indebtedness (as defined in the Credit Agreement), less subordinated indebtedness, to Consolidated Adjusted EBITDA (as defined in the Credit Agreement) not exceeding &lt;font class="_mt"&gt;4.25&lt;/font&gt;:1.00. In connection with the credit facility, the Company incurred $&lt;font class="_mt"&gt;2.9&lt;/font&gt; million of debt issuance costs.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest on the Company's credit facility was payable at (x) the sum of (i) an applicable margin ranging from &lt;font class="_mt"&gt;1.50&lt;/font&gt;% to &lt;font class="_mt"&gt;2.25&lt;/font&gt;% based on the applicable senior leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the "prime rate," (b) the sum of the federal funds rate plus a margin of &lt;font class="_mt"&gt;0.50&lt;/font&gt;% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than &lt;font class="_mt"&gt;0.00&lt;/font&gt;%) plus a margin of &lt;font class="_mt"&gt;1.00&lt;/font&gt;% or (y) the sum of (i) an applicable margin ranging from &lt;font class="_mt"&gt;2.50&lt;/font&gt;% to &lt;font class="_mt"&gt;3.25&lt;/font&gt;% based on the applicable leverage ratio plus (ii) the offered rate per annum for the applicable interest period that appears on Reuters Screen LIBOR01 Page. Swing loans may not be LIBOR loans.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company paid a fee ranging from 0.25% to 0.50% based on the applicable leverage ratio times the unused portion of the revolving portion of the credit facility.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;During the nine months ended September 30, 2018, the Company drew a total of approximately $&lt;font class="_mt"&gt;60.4&lt;/font&gt; million on its delayed draw term loan under the credit facility to fund the acquisitions of Ambercare and Arcadia. The Company did &lt;font class="_mt"&gt;no&lt;/font&gt;t draw on the term loan during the three months ended September 30, 2018.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;As of September 30, 2018, the Company had a total of $&lt;font class="_mt"&gt;103.2&lt;/font&gt; million of term loans outstanding with an interest rate of &lt;font class="_mt"&gt;4.60&lt;/font&gt;% on the credit facility and the total availability under the revolving credit loan facility was $&lt;font class="_mt"&gt;88.6&lt;/font&gt; million.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;As of December 31, 2017, the Company had a total of $&lt;font class="_mt"&gt;44.4&lt;/font&gt; million of term loans outstanding with an interest rate of &lt;font class="_mt"&gt;3.86&lt;/font&gt;% on the credit facility and the total availability under the revolving credit loan facility was $&lt;font class="_mt"&gt;105.1&lt;/font&gt; million.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Terminated Senior Secured Credit Facility&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prior to May 8, 2017, the Company was a party to the Terminated Senior Secured Credit Agreement with certain lenders and Fifth Third Bank, as agent and letters of credit issuer. The Terminated Senior Secured Credit Facility provided a $&lt;font class="_mt"&gt;100.0&lt;/font&gt; million revolving line of credit, a delayed draw term loan facility of up to $&lt;font class="_mt"&gt;25.0&lt;/font&gt; million and an uncommitted incremental term loan facility of up to $&lt;font class="_mt"&gt;50.0&lt;/font&gt; million, which was to expire on&amp;nbsp;&lt;font class="_mt"&gt;November 10, 2020&lt;/font&gt; and included a $&lt;font class="_mt"&gt;35.0&lt;/font&gt; million sublimit for the issuance of letters of credit. Substantially all of the subsidiaries of Holdings were co-borrowers, and Holdings had guaranteed the borrowers' obligations under the Terminated Senior Secured Credit Facility. The Terminated Senior Secured Credit Facility was secured by a first priority security interest in all of Holdings' and the borrowers' current and future tangible and intangible assets, including the shares of stock of the borrowers.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: center;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Item-249" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">18205000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities id="Item-248" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">134775000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Item-232" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">-23108000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities id="Item-231" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">-65731000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Item-225" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">42578000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities id="Item-224" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">24679000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLoss id="Item-425" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">10366000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Item-423" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">3408000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Item-882" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">12701000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Item-881" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="-3">12701000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="Item-422" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">3546000</us-gaap:NetIncomeLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="Item-538" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 replaced most existing revenue recognition guidance in GAAP. The Company adopted the new standard on January 1, 2018, and elected to adopt using the modified retrospective method. See Note 2 for additional information regarding the adoption.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In August 2016, the FASB issued ASU 2016-15, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;This standard amends and adjusts how cash receipts and cash payments are presented and classified in the statement of cash flows. We adopted the standard on a retrospective basis on January 1, 2018. ASU 2016-15 did not have an impact on our Condensed Consolidated Statements of Cash Flows.&lt;/font&gt;&lt;/p&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Recently Issued Accounting Pronouncements&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In February 2016, the FASB issued ASU 2016-02, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Leases (Topic 842), &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;which replaces existing leasing rules with a comprehensive lease measurement and recognition standard and expanded disclosure requirements. ASU 2016-02 will require lessees to recognize most leases on their balance sheets as liabilities, with corresponding "right-of-use" assets and is effective for annual reporting periods beginning after December 15, 2018, subject to early adoption. For income statement recognition purposes, leases will be classified as either a finance or an operating lease. In July 2018, the FASB issued ASU 2018-11, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Leases (Topic 842) Targeted Improvements&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, which amends ASU 2016-02 to provide an additional transition method option. Under the new transition method, an entity initially applies the new lease standard at the adoption date, versus at the beginning of the earliest period presented, and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Upon initial evaluation, the Company believes that the new standard will have a material impact on its consolidated balance sheets but it will not affect its liquidity. The Company has secured new software to account for the change in accounting for leases and is currently assessing the impact of adopting this standard.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Financial Instruments&amp;#8212;Credit Losses (Topic 326)&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;: &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Measurement of Credit Losses on Financial Instruments. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. ASU 2016-13 is effective as of January 1, 2020. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2016-13.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Intangibles&amp;#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit's carrying amount over its fair value (i.e., measure the charge based on the current Step 1). ASU 2017-04 is effective for annual and any interim impairment tests for periods beginning after December 15, 2019. Early adoption is permitted. The Company is currently assessing the impact of adopting this standard.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification ("ASC") 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. The ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2019. Early adoption is permitted. The Company is currently assessing the impact of adopting this standard.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NumberOfOperatingSegments id="Item-539" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit18" decimals="INF">3</us-gaap:NumberOfOperatingSegments>
  <us-gaap:NumberOfReportableSegments id="Item-839" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit18" decimals="INF">3</us-gaap:NumberOfReportableSegments>
  <us-gaap:OperatingExpenses id="Item-395" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">66193000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="Item-393" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">23246000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="Item-394" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">82974000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses id="Item-392" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">30802000</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss id="Item-399" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">18688000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-863" contextRef="Duration_1_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">54544000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-862" contextRef="Duration_1_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">54544000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-397" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">5807000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-851" contextRef="Duration_7_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">18990000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-850" contextRef="Duration_7_1_2017_To_9_30_2017_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">18990000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-398" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">17356000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-828" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">67771000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-810" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">178000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-809" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">3085000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-808" contextRef="Duration_1_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">64508000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-396" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">5903000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-827" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember" unitRef="Unit1" decimals="-3">24132000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-786" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">96000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-785" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">1864000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="Item-784" contextRef="Duration_7_1_2018_To_9_30_2018_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">22172000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="Item-535" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;1. Nature of Operations, Consolidation, and Presentation of Financial Statements&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;div&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Addus HomeCare Corporation ("Holdings") and its subsidiaries (together with Holdings, the "Company", "we", "us" or "our") operate as&amp;nbsp;&lt;font class="_mt"&gt;three&lt;/font&gt; segments as a multi-state provider of personal care, hospice and home health services in the home. The Company's personal care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Company's hospice segment provides physical, emotional and spiritual care for people who are terminally ill as well as for&amp;nbsp;their families. The Company's home health segment provides services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery and include skilled nursing and physical, occupational and speech therapy.&amp;nbsp;&lt;/font&gt;&lt;/p&gt;

&lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;p style="text-align: left;"&gt;&lt;strong&gt;&lt;em&gt;Basis of Presentation&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2017 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period and have not been audited by our independent auditors.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Principles of Consolidation&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;These unaudited condensed consolidated financial statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company used the cost method to account for its investment in joint ventures in which it owned 10% equity interests. The Company sold such investments on October 1, 2017. See Note 3 "Gain on Sale of Assets" for additional information.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Reclassification of Prior Period Balances&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Certain reclassifications have been made to prior period amounts to conform to the current-year presentation including the reporting of other long-term liabilities as a separate line item on the Unaudited Condensed Consolidated Balance Sheets. These reclassifications have no effect on the reported net income.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update ("ASU") 2014-09, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASU 2014-09 replaced most existing revenue recognition guidance in GAAP. The Company adopted the new standard on January 1, 2018, and elected to adopt using the modified retrospective method. See Note 2 for additional information regarding the adoption.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In August 2016, the FASB issued ASU 2016-15, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;This standard amends and adjusts how cash receipts and cash payments are presented and classified in the statement of cash flows. We adopted the standard on a retrospective basis on January 1, 2018. ASU 2016-15 did not have an impact on our Condensed Consolidated Statements of Cash Flows.&lt;/font&gt;&lt;/p&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Recently Issued Accounting Pronouncements&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In February 2016, the FASB issued ASU 2016-02, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Leases (Topic 842), &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;which replaces existing leasing rules with a comprehensive lease measurement and recognition standard and expanded disclosure requirements. ASU 2016-02 will require lessees to recognize most leases on their balance sheets as liabilities, with corresponding "right-of-use" assets and is effective for annual reporting periods beginning after December 15, 2018, subject to early adoption. For income statement recognition purposes, leases will be classified as either a finance or an operating lease. In July 2018, the FASB issued ASU 2018-11, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Leases (Topic 842) Targeted Improvements&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, which amends ASU 2016-02 to provide an additional transition method option. Under the new transition method, an entity initially applies the new lease standard at the adoption date, versus at the beginning of the earliest period presented, and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Upon initial evaluation, the Company believes that the new standard will have a material impact on its consolidated balance sheets but it will not affect its liquidity. The Company has secured new software to account for the change in accounting for leases and is currently assessing the impact of adopting this standard.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Financial Instruments&amp;#8212;Credit Losses (Topic 326)&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;: &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Measurement of Credit Losses on Financial Instruments. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. ASU 2016-13 is effective as of January 1, 2020. Early adoption is permitted. The Company is currently evaluating the impact of ASU 2016-13.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Intangibles&amp;#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit's carrying amount over its fair value (i.e., measure the charge based on the current Step 1). ASU 2017-04 is effective for annual and any interim impairment tests for periods beginning after December 15, 2019. Early adoption is permitted. The Company is currently assessing the impact of adopting this standard.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification ("ASC") 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. The ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2019. Early adoption is permitted. The Company is currently assessing the impact of adopting this standard.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt; &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock id="Item-537" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;p style="text-align: left;"&gt;&lt;strong&gt;&lt;em&gt;Basis of Presentation&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The accompanying unaudited condensed consolidated financial statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2017 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period and have not been audited by our independent auditors.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="Item-171" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">3149000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="Item-170" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">3407000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAssets id="Item-128" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">108536000</us-gaap:OtherAssets>
  <us-gaap:OtherAssets id="Item-127" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">160260000</us-gaap:OtherAssets>
  <us-gaap:OtherAssetsCurrent id="Item-185" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">3048000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsCurrent id="Item-184" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1644000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherGeneralAndAdministrativeExpense id="Item-815" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">33110000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherGeneralAndAdministrativeExpense id="Item-814" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">11402000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherGeneralAndAdministrativeExpense id="Item-830" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">43739000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherGeneralAndAdministrativeExpense id="Item-829" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">15694000</us-gaap:OtherGeneralAndAdministrativeExpense>
  <us-gaap:OtherLiabilitiesNoncurrent id="Item-144" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">446000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="Item-143" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">641000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherNonoperatingIncome id="Item-824" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">165000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:OtherNonoperatingIncome id="Item-823" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">64000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:PaymentsForRestructuring id="Item-689" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" unitRef="Unit1" decimals="-3">856000</us-gaap:PaymentsForRestructuring>
  <us-gaap:PaymentsForRestructuring id="Item-690" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" unitRef="Unit1" decimals="-3">755000</us-gaap:PaymentsForRestructuring>
  <us-gaap:PaymentsOfDebtIssuanceCosts id="Item-243" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">2823000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:PaymentsOfDebtIssuanceCosts id="Item-242" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">73000</us-gaap:PaymentsOfDebtIssuanceCosts>
  <us-gaap:PaymentsToAcquireBusinessesGross id="Item-14" contextRef="Duration_1_1_2018_To_1_1_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-5">3300000</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:PaymentsToAcquireBusinessesGross id="Item-33" contextRef="Duration_9_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AffiliateBranchesOfArcadiaMember" unitRef="Unit1" decimals="-5">600000</us-gaap:PaymentsToAcquireBusinessesGross>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="Item-228" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">22419000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired id="Item-227" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">62347000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Item-230" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">3089000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="Item-229" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">3384000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy id="Item-747" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Allowance for Doubtful Accounts&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;For 2017, the Company established its allowance for doubtful accounts to the extent it was probable that a portion or all of a particular account will not be collected. The Company established its provision for doubtful accounts primarily by reviewing the creditworthiness of significant customers and through evaluations over the collectability of the receivables. An allowance for doubtful accounts was maintained at a level that the Company's management believed was sufficient to cover potential losses.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In 2018, subsequent adjustments that are determined to be the result of an adverse change in the payor's ability to pay are recognized as bad debt expense due to the adoption of ASU 2014-09, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;. The Company recorded $&lt;font class="_mt"&gt;2.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;6.8&lt;/font&gt; million for the three and nine months ended September 30, 2018 as a reduction to revenue that would have been recorded as bad debt expense under the prior revenue recognition guidance.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PremiumsReceivableAllowanceForDoubtfulAccountsEstimationMethodologyPolicy>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Item-187" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">8379000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent id="Item-186" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">6935000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidInsurance id="Item-177" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">2901000</us-gaap:PrepaidInsurance>
  <us-gaap:PrepaidInsurance id="Item-176" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1457000</us-gaap:PrepaidInsurance>
  <us-gaap:PrepaidRent id="Item-181" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">555000</us-gaap:PrepaidRent>
  <us-gaap:PrepaidRent id="Item-180" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">1208000</us-gaap:PrepaidRent>
  <us-gaap:PriorPeriodReclassificationAdjustmentDescription id="Item-536" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Reclassification of Prior Period Balances&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Certain reclassifications have been made to prior period amounts to conform to the current-year presentation including the reporting of other long-term liabilities as a separate line item on the Unaudited Condensed Consolidated Balance Sheets. These reclassifications have no effect on the reported net income.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
  <us-gaap:ProceedsFromDivestitureOfBusinesses id="Item-281" contextRef="Duration_3_1_2017_To_3_1_2017_srt_StatementGeographicalAxis_stpr_IL" unitRef="Unit1" decimals="-5">2400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Item-234" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">76618000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Item-749" contextRef="Duration_8_20_2018_To_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_PrimarySharesMember" unitRef="Unit1" decimals="-5">59100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="Item-716" contextRef="Duration_8_22_2018_To_8_22_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember" unitRef="Unit1" decimals="-5">17500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="Item-237" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">45000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromIssuanceOfLongTermDebt id="Item-236" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">60420000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
  <us-gaap:ProceedsFromLinesOfCredit id="Item-233" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">30000000</us-gaap:ProceedsFromLinesOfCredit>
  <us-gaap:ProceedsFromLongTermLinesOfCredit id="Item-235" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">20000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
  <us-gaap:ProceedsFromLongTermLinesOfCredit id="Item-532" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember" unitRef="Unit1" decimals="-5">60400000</us-gaap:ProceedsFromLongTermLinesOfCredit>
  <us-gaap:ProceedsFromLongTermLinesOfCredit id="Item-443" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_DebtInstrumentAxis_adus_CreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_adus_CapitalOneMember_us-gaap_LongtermDebtTypeAxis_adus_DelayedDrawTermLoanMember" unitRef="Unit1" decimals="-5">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
  <us-gaap:ProceedsFromSaleOfEquityMethodInvestments id="Item-276" contextRef="Duration_10_1_2017_To_10_1_2017_dei_LegalEntityAxis_adus_LhcGroupIncMember" unitRef="Unit1" decimals="-5">1300000</us-gaap:ProceedsFromSaleOfEquityMethodInvestments>
  <us-gaap:ProceedsFromSaleOfProductiveAssets id="Item-226" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">2400000</us-gaap:ProceedsFromSaleOfProductiveAssets>
  <us-gaap:ProceedsFromStockOptionsExercised id="Item-247" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">1158000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromStockOptionsExercised id="Item-246" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">450000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:PropertyPlantAndEquipmentNet id="Item-121" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">7489000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="Item-120" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">9453000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="Item-742" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Property and Equipment&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment are recorded at cost and depreciated over the estimated useful lives of the related assets by use of the straight-line method. Maintenance and repairs are charged to expense as incurred. The estimated useful lives of the property and equipment are as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="39%"&gt; &lt;/td&gt;
&lt;td width="60%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3 &amp;#8211; 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 &amp;#8211; 7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Transportation equipment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer software&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 &amp;#8211;10 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Lesser of useful life or lease term, unless&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;probability of lease renewal is likely&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Item-761" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_TransportationEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Item-763" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_adus_ComputerSoftwareMember">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Item-758" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Item-760" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Item-762" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_adus_ComputerSoftwareMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Item-757" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:PropertyPlantAndEquipmentUsefulLife id="Item-759" contextRef="Duration_1_1_2018_To_9_30_2018_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-859" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">6208000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-858" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">6208000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-847" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">2106000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-846" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">2106000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-803" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">214000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-802" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">1000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-801" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">3000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-800" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">210000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-779" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">49000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-778" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">1000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:ProvisionForDoubtfulAccounts id="Item-777" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">48000</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:RepaymentsOfLinesOfCredit id="Item-239" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">30000000</us-gaap:RepaymentsOfLinesOfCredit>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="Item-245" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">1067000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations id="Item-244" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">952000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
  <us-gaap:RepaymentsOfLongTermDebt id="Item-241" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">24063000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock id="Item-682" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;10. Severance and Restructuring&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In 2016, the Company initiated steps to streamline its operations. The Company incurred total expenses related to these initiatives of approximately $&lt;font class="_mt"&gt;0.3&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.6&lt;/font&gt; million for the three months ended September 30, 2018 and 2017, respectively, and $&lt;font class="_mt"&gt;1.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;1.5&lt;/font&gt; million for the nine months ended September 30, 2018 and 2017, respectively. These costs are included in general and administrative expenses on the Company's Unaudited Condensed Consolidated Statements of Income. The expenses recorded for the three and nine months ended September 30, 2018 included costs related to terminated employees and other professional fees. The expenses recorded for the three and nine months ended September 30, 2017 included costs related to terminated employees and fees related to the termination of professional service relationships. The Company expects some additional restructuring and other costs to occur, however, the amount and timing cannot be determined at this time.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The following provides the components of and changes in our severance and restructuring accruals:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="42%"&gt; &lt;/td&gt;
&lt;td width="14%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="6%"&gt; &lt;/td&gt;
&lt;td width="13%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Employee&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Termination&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Restructuring&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Costs&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;and Other&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Balance at December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;562&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,077&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;610&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;285&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Utilization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(856&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(755&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Balance at September 30, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;316&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;607&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Employee termination costs represent accrued severance payable to terminated employees with employment and/or separation agreements with the Company.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Restructuring and other costs consists of the accrual related to lease commitments and write-offs of leasehold improvements and unused office space and property and equipment resulting from the closure of three adult day services centers in Illinois.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The aforementioned accruals are included in Accrued Expenses on the Unaudited Condensed Consolidated Balance Sheets and the aforementioned expenses are included in General and Administrative Expenses on the Unaudited Condensed Consolidated Statements of Income.&lt;/font&gt;&lt;/p&gt; &lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
  <us-gaap:RestructuringCharges id="Item-207" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">383000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCharges id="Item-687" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" unitRef="Unit1" decimals="-3">610000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCharges id="Item-688" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" unitRef="Unit1" decimals="-3">285000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringReserve id="Item-685" contextRef="As_Of_12_31_2017_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" unitRef="Unit1" decimals="-3">562000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve id="Item-686" contextRef="As_Of_12_31_2017_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" unitRef="Unit1" decimals="-3">1077000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve id="Item-691" contextRef="As_Of_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" unitRef="Unit1" decimals="-3">316000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve id="Item-692" contextRef="As_Of_9_30_2018_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" unitRef="Unit1" decimals="-3">607000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringSettlementAndImpairmentProvisions id="Item-683" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">1500000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
  <us-gaap:RestructuringSettlementAndImpairmentProvisions id="Item-684" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-5">600000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
  <us-gaap:RestructuringSettlementAndImpairmentProvisions id="Item-693" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">1400000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
  <us-gaap:RestructuringSettlementAndImpairmentProvisions id="Item-694" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-5">300000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Item-154" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">79105000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="Item-153" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">91806000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock id="Item-681" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div&gt;

&lt;p style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: center; color: rgb(0,0,0);"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The percentages of segment revenue for each of the Company's significant states for the three and nine months ended September 30, 2018 and 2017 were as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; color: rgb(0,0,0);" align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="93%" colspan="16" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="47%" colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="46%" colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="23%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="24%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="25%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="21%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="9%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="9%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="9%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="9%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="9%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Illinois&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;58,863&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;46.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;56,813&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;52.3&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;174,457&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;48.2&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;165,370&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;52.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New York&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,814&lt;/font&gt;&lt;/td&gt;
&lt;td width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.1&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,904&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.7&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;47,999&lt;/font&gt;&lt;/td&gt;
&lt;td width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.2&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;43,562&lt;/font&gt;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;13.9&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New Mexico&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,013&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12.5&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10,645&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;9.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;42,594&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,854&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7.9&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;All other&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="9%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 3px;" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;states&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;36,404&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;28.4&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;26,230&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24.2&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;97,556&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;26.9&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;79,972&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;25.5&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total personal&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="9%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 3px;" bgcolor="#ccffff" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;care&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="9%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 3px;" bgcolor="#ccffff" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;segment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="9%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 3px;" bgcolor="#ccffff" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;net service&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="9%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" width="7%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;128,094&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;362,606&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div&gt;

&lt;div style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; color: rgb(0,0,0);" align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr valign="bottom"&gt;&lt;td width="63%" colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New Mexico&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 9px;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,765&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total hospice segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 9px;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,765&lt;/font&gt;&lt;/td&gt;
&lt;td width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td width="100%" colspan="9"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="63%" colspan="8" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended&lt;/font&gt;&lt;/b&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt; &lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt; &lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="32%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="31%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="37%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="14%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;New Mexico&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 9px;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="37%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total home health segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 9px;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="12%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td width="14%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; color: rgb(0,0,0);"&gt;&amp;nbsp;&lt;/p&gt;&lt;br /&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/p&gt; &lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="Item-713" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue Recognition&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On January 1, 2018, the Company adopted ASU 2014-09, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The Company adopted the standard using the modified retrospective approach and did not record a cumulative catch-up adjustment as the timing and measurement of revenue for the Company's customers is similar to its prior revenue recognition model. However, the majority&amp;nbsp;of what historically was classified&amp;nbsp;as provision for doubtful accounts expense under operating expenses&amp;nbsp;is now treated as an implicit price concession factored into net service revenues.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;u&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Personal Care&lt;/font&gt;&lt;/u&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The majority of the Company's net service revenues are generated from providing personal care services directly to consumers under contracts with state, local and other governmental agencies, managed care organizations, commercial insurers and private consumers. Generally, these contracts, which are negotiated based on current contracting practices as appropriate for the payor, establish the terms of a customer relationship and set the broad range of terms for services to be performed at a stated rate. However, the contracts do not give rise to rights and obligations until an order is placed with the Company. When an order is placed, it creates the performance obligation to provide a defined quantity of service hours, or authorized hours, per consumer. The Company satisfies its performance obligations over time, given that consumers simultaneously receive and consume the benefits provided by the Company as the services are performed. As the Company has a right to consideration from customers commensurate with the value provided to customers from the performance completed over a given invoice period, the Company has elected to use the practical expedient for measuring progress toward satisfaction of performance obligations and recognizes patient service revenue in the amount to which the Company has a right to invoice.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;u&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Hospice Revenue&lt;/font&gt;&lt;/u&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company generates net service revenues from providing hospice services to consumers who are terminally ill as well as for&amp;nbsp;their families. Net service revenues are recognized as services are provided and costs for delivery of such services are incurred. The estimated payment rates are daily rates for each of the levels of care the Company delivers.&amp;nbsp;Hospice companies are subject to two specific payment limit caps under the Medicare program each federal fiscal year: the inpatient cap and the aggregate cap. The inpatient cap limits the number of inpatient care days provided to no more than 20% of the total days of hospice care provided for the year. The aggregate cap limits the amount of Medicare reimbursement a hospice may receive, based on the number of Medicare patients served. For federal fiscal year 2018, which ended September 30, 2018, the Company was below the payment limits and did not record a cap liability.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;u&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Home Health Revenue&lt;/font&gt;&lt;/u&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company also generates net service revenues from providing home healthcare services directly to consumers under contracts with Medicare. Generally, these contracts, which are negotiated based on current contracting practices as appropriate for the payor, establish the terms of a&amp;nbsp;relationship and set the broad range of terms for services to be performed on an episodic basis at a stated rate. Home health Medicare services are paid under the Medicare Home Health Prospective Payment System ("HHPPS"), which is based on 60 day episodes of care. The HHPPS permits multiple, continuous episodes per patient. Medicare payment rates for episodes under HHPPS vary based on the severity of the patient's condition as determined by the Company's assessment of a patient's Home Health Resource Group score. The Company elects to use the same 60-day length of episode that Medicare recognizes as standard but accelerates revenue upon discharge to align with a patient's episode length if less than the expected 60 days, which depicts the transfer of services and related benefits received by the patient over the term of the contract necessary to satisfy the obligations. The Company recognizes revenue based on the number of days elapsed during an episode of care within the reporting period. The Company satisfies its performance obligations as consumers receive and consume the benefits provided by the Company as the services are performed. As the Company has a right to consideration from Medicare commensurate with the services provided to customers from the performance completed over a given episodic period, the Company has elected to use the practical expedient for measuring progress toward satisfaction of performance obligations. Under this method recognizing revenue ratably over the episode based on beginning and ending dates is a reasonable proxy for the transfer of benefit of the service.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:Revenues id="Item-853" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">313758000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-852" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">313758000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-44" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">3300000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-676" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">313758000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-580" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">313758000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-572" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">79972000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-548" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">165370000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-564" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">24854000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-556" contextRef="Duration_1_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">43562000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-664" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">2064000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-648" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">102055000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-656" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">6230000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-640" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">203409000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-841" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">108592000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-840" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">108592000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-13" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">3300000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-672" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">108592000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-576" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">108592000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-568" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">26230000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-544" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">56813000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-560" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">10645000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-552" contextRef="Duration_7_1_2017_To_9_30_2017_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">14904000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-660" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">694000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-644" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">36866000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-652" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">1959000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-636" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">69073000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-791" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">378315000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-15" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">22600000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-48" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-5">21700000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-790" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">3944000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-789" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">11765000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-788" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">362606000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-719" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member" unitRef="Unit1" decimals="-5">-6800000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-71" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-5">1800000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-51" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-5">4500000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-34" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">13400000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-624" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">3944000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-608" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">11765000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-674" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">362606000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-592" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">3944000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-632" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">11765000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-578" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">362606000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-570" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">97556000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-546" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">174457000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-588" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">3944000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-628" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">11765000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-562" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">42594000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-554" contextRef="Duration_1_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">47999000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-662" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">4271000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-616" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">329000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-600" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">721000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-646" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">126809000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-612" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">3588000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-596" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">11030000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-620" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">27000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-604" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">14000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-668" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">3654000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-654" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">14861000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-638" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">213011000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-768" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">137631000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-73" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember" unitRef="Unit1" decimals="-5">13400000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-31" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember" unitRef="Unit1" decimals="-5">10900000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-767" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2421000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-766" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">7116000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-765" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">128094000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-745" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_us-gaap_AccountingStandardsUpdate201409Member" unitRef="Unit1" decimals="-5">-2400000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-30" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_AZ_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember" unitRef="Unit1" decimals="-5">700000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-76" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember" unitRef="Unit1" decimals="-5">1500000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-45" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember" unitRef="Unit1" decimals="-5">4500000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-622" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2421000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-606" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">7116000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-670" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">128094000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-590" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2421000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-630" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">7116000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-574" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">128094000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-566" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_adus_AllOtherStatesMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">36404000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-542" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_IL_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">58863000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-586" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2421000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-626" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">7116000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-558" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NM_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">16013000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-550" contextRef="Duration_7_1_2018_To_9_30_2018_srt_StatementGeographicalAxis_stpr_NY_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_GeographicConcentrationRiskMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">16814000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-658" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_CommercialInsuranceMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">1869000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-614" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">221000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-598" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">426000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-642" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_ManagedCareOrganizationsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">45271000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-610" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">2184000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-594" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_MedicareMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">6677000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-618" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HomeHealthMember" unitRef="Unit1" decimals="-3">16000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-602" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_HospiceMember" unitRef="Unit1" decimals="-3">13000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-666" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_OtherMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">1799000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-650" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_PrivatePayMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">5549000</us-gaap:Revenues>
  <us-gaap:Revenues id="Item-634" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueServicesNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_us-gaap_HealthCareOrganizationRevenueSourcesAxis_adus_StateLocalAndOtherGovernmentalProgramsMember_us-gaap_StatementBusinessSegmentsAxis_adus_PersonalCareMember" unitRef="Unit1" decimals="-3">73606000</us-gaap:Revenues>
  <us-gaap:SaleOfStockPricePerShare id="Item-729" contextRef="As_Of_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_SecondaryPublicOfferingMember" unitRef="Unit17" decimals="2">59.00</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock id="Item-190" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt; &lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="5"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;December 31, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="3" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued payroll&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 3px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;27,236&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;19,783&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued workers' compensation insurance&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,846&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,574&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued health insurance (1)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,165&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,471&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued professional fees&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,242&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,312&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued payroll taxes&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,540&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,065&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,407&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,149&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;52,436&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;44,354&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&lt;/p&gt;&lt;a name="page_18"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1) The Company provides health insurance coverage to qualified union employees providing personal care services in Illinois through a Taft-Hartley multi-employer health and welfare plan under Section 302(c)(5) of the Labor Management Relations Act of 1947. The Company's insurance contributions equal the amount reimbursed by the State of Illinois. Contributions are due within five business days from the date the funds are received from the State of Illinois. &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Amounts due of $1.2 million and $2.3 million for health insurance reimbursements and contributions were reflected in prepaid insurance and accrued insurance as of September 30, 2018 and December 31, 2017, respectively.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock id="Item-474" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="51%"&gt; &lt;/td&gt;
&lt;td width="18%"&gt; &lt;/td&gt;
&lt;td width="26%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Asset Balances at&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Classes of Property&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,484&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;868&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;635&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer software&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;303&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Transportation equipment&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;107&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,397&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less: accumulated depreciation and amortization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,772&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,625&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock>
  <us-gaap:ScheduleOfDebtInstrumentsTextBlock id="Item-534" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="43%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="17%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;
&lt;td width="17%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;December 31, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Term loan under the credit facility&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;103,170&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;44,438&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Capital leases&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;142&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,002&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less unamortized issuance costs&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,103&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,481&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;101,209&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;42,959&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less current maturities&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,318&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(3,099&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Long-term debt&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;98,891&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;39,860&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
  <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock id="Item-341" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="51%"&gt; &lt;/td&gt;
&lt;td width="26%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="14%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Federal income tax at statutory rate&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;21.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;State and local taxes, net of federal benefit&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5.3&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.4&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Jobs tax credits, net&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(10.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(7.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Nondeductible permanent items&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2.0&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2.4&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective income tax rate&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;20.7&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32.2&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="5"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Federal income tax at statutory rate&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;21.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;State and local taxes, net of federal benefit&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.9&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Jobs tax credits, net&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(9.3&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(7.5&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Nondeductible permanent items&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.5&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.9&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(0.8&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective income tax rate&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;20.6&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32.1&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock id="Item-533" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="59%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="21%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 1px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Capital Lease&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 2px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts In&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2018&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;65&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2019&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;67&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2020&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;20&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;152&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less: amount representing estimated executory&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;costs (such as taxes, maintenance and&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;insurance), including profit thereon,&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;included in total minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(5&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;147&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Less: amount representing interest&lt;/font&gt;&lt;sup&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1)&lt;/font&gt;&lt;/sup&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(5&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Present value of net minimum lease payments&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;(2&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;142&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td valign="top" width="2%"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1)&lt;/font&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &lt;/td&gt;
&lt;td width="98%"&gt;

&lt;div&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Amount necessary to reduce net minimum lease payments to present value calculated at the Company's incremental borrowing rate at lease inception.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td valign="top" width="2%"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2)&lt;/font&gt;&amp;nbsp; &amp;nbsp; &amp;nbsp; &lt;/td&gt;
&lt;td width="98%"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Included in the balance sheet as $114,000 of the current portion of long-term debt and $28,000 of the long-term debt, less current portion.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumLeasePaymentsForCapitalLeasesTableTextBlock>
  <us-gaap:ScheduleOfGoodwillTextBlock id="Item-325" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="38%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="24%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="3" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Goodwill&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 1px;" colspan="3" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill as of December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;90,339&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 1px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;90,339&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Additions for acquisitions&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;22,185&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;19,040&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,499&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;43,724&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill as of September 30, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;112,524&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;19,040&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,499&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;134,063&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
  <us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock id="Item-290" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="29%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="1%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Customer&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Trade&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;and referral&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;names and&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Non-competition&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;State&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;relationships&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;trademarks&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;agreements&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Licenses&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross balance at December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;39,017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,641&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,155&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;55,813&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accumulated amortization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(29,147&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(8,198&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,872&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(39,217&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net balance at December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;9,870&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,443&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;283&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,596&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross balance at January 1, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;39,017&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,641&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,155&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;55,813&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Additions for acquisitions&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,209&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,927&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,376&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,512&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accumulated amortization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(32,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(9,942&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,954&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(101&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(44,128&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net balance at September 30, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,095&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,626&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;201&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,275&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;26,197&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock>
  <us-gaap:ScheduleOfOtherAssetsTableTextBlock id="Item-175" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="55%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="12%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="17%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;December 31, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 3px;" colspan="3" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prepaid health insurance&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,457&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,901&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Workers' compensation insurance receivable&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,375&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;543&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prepaid rent&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,208&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;555&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Prepaid workers' compensation and liability&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;insurance&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,251&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,332&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 10px;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,644&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,048&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,935&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;8,379&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock id="Item-111" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_AmbercareCorporationMember">&lt;div&gt; &lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="56%"&gt; &lt;/td&gt;
&lt;td width="23%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;28,082&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cash&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,008&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10,413&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,638&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;440&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;171&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(3,732&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Deferred tax liability&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,302&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Capital lease&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(93&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(3&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;51,622&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock id="Item-78" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_ArcadiaHomeCareAndStaffingMember">&lt;div&gt; &lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="54%"&gt; &lt;/td&gt;
&lt;td width="22%"&gt; &lt;/td&gt;
&lt;td width="18%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 2px;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,389&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,317&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,947&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;155&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;92&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(1,540&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(508&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,852&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock id="Item-109" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_LifestyleOptionsIncMember">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="55%"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="37%" align="center"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="37%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="37%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" width="37%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,751&lt;/font&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,152&lt;/font&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;573&lt;/font&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32&lt;/font&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18&lt;/font&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(291&lt;/font&gt;&lt;/td&gt;
&lt;td width="4%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(105&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 1px solid;" width="4%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="55%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 3px double;" width="37%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,130&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: #000000 3px double;" width="4%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock id="Item-35" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_OptionsHomeCareMember">&lt;div&gt; &lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="56%"&gt; &lt;/td&gt;
&lt;td width="23%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="4%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;16,671&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,324&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,084&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cash&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;205&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;41&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(701&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;22,624&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock id="Item-110" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_BusinessAcquisitionAxis_adus_SunCitiesHomecareMember">&lt;div&gt; &lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr valign="bottom"&gt;&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,089&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Identifiable intangible assets&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;682&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts receivable&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;254&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cash&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;321&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other assets&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accrued liabilities&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(86&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(14&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total purchase price allocation&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,256&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt; &lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock id="Item-695" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="42%"&gt; &lt;/td&gt;
&lt;td width="14%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="6%"&gt; &lt;/td&gt;
&lt;td width="13%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Employee&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Termination&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Restructuring&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Costs&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;and Other&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="4" align="right"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Balance at December 31, 2017&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;562&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,077&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;610&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;285&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Utilization&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(856&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(755&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Balance at September 30, 2018&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;316&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;607&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
  <us-gaap:ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock id="Item-680" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="11%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="8%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="10%"&gt; &lt;/td&gt;
&lt;td width="7%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="88%" colspan="15" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="43%" colspan="6" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="32%" colspan="5" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="21%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="text-indent: 3px;" width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Net Service&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="11%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt; &lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="8%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;State, local and&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;other&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;governmental&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;programs&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;73,606&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;57.5&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;69,073&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;63.6&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;213,011&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;58.7&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;% &lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;203,409&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;64.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Managed care&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;organizations&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;45,271&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.3&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;36,866&lt;/font&gt;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;34.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;126,809&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;35.0&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;102,055&lt;/font&gt;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32.5&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Private pay&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,549&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.3&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,959&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;14,861&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4.1&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,230&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Commercial&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;insurance&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,869&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.5&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;694&lt;/font&gt;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.6&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,271&lt;/font&gt;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.2&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,064&lt;/font&gt;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;0.7&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,799&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.4&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,654&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt; &lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total personal&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;care segment&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;net service&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="11%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="8%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt; &lt;/td&gt;
&lt;td width="10%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="text-indent: 3px;" width="10%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="11%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;128,094&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="8%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;362,606&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;% &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="32%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="9%" align="center"&gt; &lt;/td&gt;
&lt;td width="18%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="1%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt; &lt;/td&gt;
&lt;td width="19%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="32%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="61%" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="32%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="27%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="29%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="32%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 5px;" width="27%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="29%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="32%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="27%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="29%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td width="95%" colspan="9" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="32%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="9%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="18%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="19%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="32%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="9%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="18%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="19%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#94fafa" width="32%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Medicare&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;6,677&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="18%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;93.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="2%" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;11,030&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="19%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;93.8&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="32%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Managed care organizations&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;426&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="18%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;6.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;721&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="19%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;6.1&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#94fafa" width="32%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;13&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="18%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;0.2&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;14&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="19%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;0.1&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="32%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Total hospice segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="9%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="18%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;11,765&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="19%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="31%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="9%" align="center"&gt; &lt;/td&gt;
&lt;td width="17%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt; &lt;/td&gt;
&lt;td width="17%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 5px;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 8px;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Ended September 30,&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Amount&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;% of Segment Net&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Service Revenues&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#94fafa" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Medicare&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;2,184&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;90.2&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;3,588&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;91.0&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#94fafa" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Managed care organizations&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;221&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;9.1&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;329&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;8.3&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#94fafa" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Other&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;16&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;0.7&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;27&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;0.7&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#94fafa" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;Total home health segment net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;100.0&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="1"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt; &lt;/div&gt;</us-gaap:ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock>
  <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock id="Item-864" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="42%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;
&lt;td width="26%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="6%" align="center"&gt; &lt;/td&gt;
&lt;td width="1%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;
&lt;td width="7%" align="center"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="55%" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="55%" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 1px;" width="8%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;128,094&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;137,631&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;95,428&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,777&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,721&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100,926&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32,666&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,339&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;700&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;36,705&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;48&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;49&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10,446&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,474&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;604&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,524&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;22,172&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,864&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;96&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,132&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td width="100%" colspan="9"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="48%" colspan="6" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="55%" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 1px;" width="8%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;362,606&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" size="2"&gt;11,765&lt;/font&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;378,315&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;268,815&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,351&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,819&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;277,985&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;93,791&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,414&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,125&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100,330&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;210&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;214&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;29,073&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,326&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;946&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32,345&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;64,508&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,085&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;178&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;67,771&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="53%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="16%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="15%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="53%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment Reconciliation:&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="36%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,132&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;67,771&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Items not allocated at segment level:&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other general and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;15,694&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;43,739&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Depreciation and amortization&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,535&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,676&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest income&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(113&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,468&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest expense&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,543&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,836&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Income before income taxes&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,473&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;15,988&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;

&lt;div&gt;

&lt;p style="margin: 0px;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&lt;/p&gt;

&lt;div&gt;&amp;nbsp;&lt;/div&gt;&lt;a name="page_24"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="40%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="24%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="6%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="6%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;79,539&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;79,539&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;29,053&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;29,053&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,106&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,106&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,957&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,957&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,990&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,990&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="9"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;228,877&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;228,877&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;84,881&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;84,881&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,208&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,208&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,129&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,129&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;54,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;54,544&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="53%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="16%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="53%" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment Reconciliation:&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="36%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,990&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;54,544&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Items not allocated at segment level:&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other general and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,402&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;33,110&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gain on sale of assets&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,065&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Depreciation and amortization&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,781&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,811&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest income&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(30&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(50&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest expense&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;870&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,629&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(64&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(165&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Income before income taxes&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,031&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;15,274&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
  <us-gaap:SegmentReportingDisclosureTextBlock id="Item-764" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;11. Segment Information&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by our chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. Our operations involve servicing patients through our&amp;nbsp;&lt;font class="_mt"&gt;three&lt;/font&gt; reportable business segments: personal care, hospice and home health. As a result of the acquisition of Ambercare on May 1, 2018, we began reporting the hospice and home health segments.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Our personal care segment provides non-medical assistance with activities of daily living, primarily to persons who are&amp;nbsp;at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. Our hospice segment provides physical, emotional and spiritual care for people who are terminally ill as well as for&amp;nbsp;their families. Our home health segment provides services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The tables below set forth information about our reportable segments for the three and nine months ended September 30, 2018 and 2017 along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. Segment assets are not reviewed by the company's chief decision makers and therefore are not disclosed below.&lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;nbsp;&amp;nbsp; &lt;/font&gt;&lt;/p&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Segment operating income consists of the net service revenues generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="42%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;
&lt;td width="26%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="6%" align="center"&gt; &lt;/td&gt;
&lt;td width="1%" align="center"&gt; &lt;/td&gt;
&lt;td width="10%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;
&lt;td width="7%" align="center"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="55%" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="55%" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 1px;" width="8%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;128,094&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,116&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,421&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;137,631&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;95,428&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,777&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,721&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100,926&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32,666&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,339&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;700&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;36,705&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;48&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;49&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;10,446&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,474&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;604&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;12,524&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;22,172&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,864&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;96&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,132&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td width="100%" colspan="9"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="48%" colspan="6" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="55%" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid; text-indent: 1px;" width="8%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;362,606&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" size="2"&gt;11,765&lt;/font&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,944&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;378,315&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;268,815&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,351&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,819&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;277,985&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;93,791&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,414&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,125&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;100,330&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;210&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3&lt;/font&gt;&lt;/td&gt;
&lt;td width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;214&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;29,073&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,326&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="1%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;946&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;32,345&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="42%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="26%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;64,508&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="6%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,085&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="1%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="10%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;178&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" width="7%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;67,771&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="53%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="16%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;
&lt;td width="2%" align="center"&gt; &lt;/td&gt;
&lt;td width="15%" align="center"&gt; &lt;/td&gt;
&lt;td width="3%" align="center"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="53%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment Reconciliation:&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2018&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="36%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in Thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,132&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;67,771&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Items not allocated at segment level:&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other general and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;15,694&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;43,739&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Depreciation and amortization&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,535&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,676&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest income&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(113&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,468&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest expense&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,543&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,836&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Income before income taxes&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,473&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;15,988&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;

&lt;div&gt;

&lt;p style="margin: 0px;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="3"&gt; &lt;/font&gt;&lt;/p&gt;

&lt;div&gt;&amp;nbsp;&lt;/div&gt;&lt;a name="page_24"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="40%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="24%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="6%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="9%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="6%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three Months Ended September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;108,592&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;79,539&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;79,539&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;29,053&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;29,053&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,106&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;2,106&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,957&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;7,957&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,990&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,990&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan="9"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine Months Ended September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" colspan="7" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Personal Care&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Hospice&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Home Health&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Total&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Net service revenues&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;313,758&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Cost of services revenues&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;228,877&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;228,877&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gross profit&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;84,881&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;84,881&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Provision for doubtful accounts&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,208&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;6,208&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;General and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,129&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;24,129&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;54,544&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="center"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;54,544&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="53%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="16%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;
&lt;td width="2%"&gt; &lt;/td&gt;
&lt;td width="15%"&gt; &lt;/td&gt;
&lt;td width="3%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Three&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;For the Nine&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Months Ended&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="53%" align="left"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;Segment Reconciliation:&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="center"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="17%" colspan="2" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;September 30, 2017&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="36%" colspan="4" align="center"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="1"&gt;(Amounts in thousands)&lt;/font&gt;&lt;/b&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Total segment operating income&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;18,990&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;54,544&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Items not allocated at segment level:&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other general and administrative expenses&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;11,402&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;33,110&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Gain on sale of assets&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;&amp;#8212;&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(2,065&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Depreciation and amortization&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;1,781&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;4,811&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest income&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(30&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(50&lt;/font&gt;&lt;/td&gt;
&lt;td width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Interest expense&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;870&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3,629&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other income&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(64&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="2%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;(165&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" width="3%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" width="53%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Income before income taxes&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="16%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5,031&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="2%" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="15%" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;15,274&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 3px double;" bgcolor="#ccffff" width="3%" align="left"&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:ShareBasedCompensation id="Item-209" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit1" decimals="-3">1818000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="Item-208" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">2961000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="Item-715" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;div&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Stock-based Compensation&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company currently has&amp;nbsp;&lt;font class="_mt"&gt;one&lt;/font&gt; stock incentive plan, the 2017 Omnibus Incentive Plan (the "2017 Plan"), under which new grants of stock-based employee compensation may be made. In addition, the Company has outstanding awards under its 2009 Stock Incentive Plan, as amended and restated. The Company accounts for stock-based compensation in accordance with ASC Topic 718, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Stock Compensation&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;. Under the 2017 Plan, compensation expense is recognized on a straight-line basis over the vesting period of the equity awards based on the grant date fair value of the options and restricted stock awards. The Company uses the Black-Scholes Option Pricing Model to value the Company's options. The determination of the fair value of stock-based payments utilizing the Black-Scholes Model is affected by the Company's stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, and expected dividends yield. Stock-based compensation expense was $&lt;font class="_mt"&gt;1.1&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.7&lt;/font&gt; million for the three months ended September 30, 2018 and 2017, respectively and $&lt;font class="_mt"&gt;3.0&lt;/font&gt; million and $&lt;font class="_mt"&gt;1.8&lt;/font&gt; million for the nine months ended September 30, 2018 and 2017, respectively.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:SharesOutstanding id="Item-865" contextRef="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit16" decimals="-3">11632000</us-gaap:SharesOutstanding>
  <us-gaap:SharesOutstanding id="Item-883" contextRef="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit16" decimals="-3">13097000</us-gaap:SharesOutstanding>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="Item-697" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;2. Summary of Significant Accounting Policies&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue Recognition&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On January 1, 2018, the Company adopted ASU 2014-09, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The Company adopted the standard using the modified retrospective approach and did not record a cumulative catch-up adjustment as the timing and measurement of revenue for the Company's customers is similar to its prior revenue recognition model. However, the majority&amp;nbsp;of what historically was classified&amp;nbsp;as provision for doubtful accounts expense under operating expenses&amp;nbsp;is now treated as an implicit price concession factored into net service revenues.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;u&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Personal Care&lt;/font&gt;&lt;/u&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The majority of the Company's net service revenues are generated from providing personal care services directly to consumers under contracts with state, local and other governmental agencies, managed care organizations, commercial insurers and private consumers. Generally, these contracts, which are negotiated based on current contracting practices as appropriate for the payor, establish the terms of a customer relationship and set the broad range of terms for services to be performed at a stated rate. However, the contracts do not give rise to rights and obligations until an order is placed with the Company. When an order is placed, it creates the performance obligation to provide a defined quantity of service hours, or authorized hours, per consumer. The Company satisfies its performance obligations over time, given that consumers simultaneously receive and consume the benefits provided by the Company as the services are performed. As the Company has a right to consideration from customers commensurate with the value provided to customers from the performance completed over a given invoice period, the Company has elected to use the practical expedient for measuring progress toward satisfaction of performance obligations and recognizes patient service revenue in the amount to which the Company has a right to invoice.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;u&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Hospice Revenue&lt;/font&gt;&lt;/u&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company generates net service revenues from providing hospice services to consumers who are terminally ill as well as for&amp;nbsp;their families. Net service revenues are recognized as services are provided and costs for delivery of such services are incurred. The estimated payment rates are daily rates for each of the levels of care the Company delivers.&amp;nbsp;Hospice companies are subject to two specific payment limit caps under the Medicare program each federal fiscal year: the inpatient cap and the aggregate cap. The inpatient cap limits the number of inpatient care days provided to no more than 20% of the total days of hospice care provided for the year. The aggregate cap limits the amount of Medicare reimbursement a hospice may receive, based on the number of Medicare patients served. For federal fiscal year 2018, which ended September 30, 2018, the Company was below the payment limits and did not record a cap liability.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&lt;u&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Home Health Revenue&lt;/font&gt;&lt;/u&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company also generates net service revenues from providing home healthcare services directly to consumers under contracts with Medicare. Generally, these contracts, which are negotiated based on current contracting practices as appropriate for the payor, establish the terms of a&amp;nbsp;relationship and set the broad range of terms for services to be performed on an episodic basis at a stated rate. Home health Medicare services are paid under the Medicare Home Health Prospective Payment System ("HHPPS"), which is based on 60 day episodes of care. The HHPPS permits multiple, continuous episodes per patient. Medicare payment rates for episodes under HHPPS vary based on the severity of the patient's condition as determined by the Company's assessment of a patient's Home Health Resource Group score. The Company elects to use the same 60-day length of episode that Medicare recognizes as standard but accelerates revenue upon discharge to align with a patient's episode length if less than the expected 60 days, which depicts the transfer of services and related benefits received by the patient over the term of the contract necessary to satisfy the obligations. The Company recognizes revenue based on the number of days elapsed during an episode of care within the reporting period. The Company satisfies its performance obligations as consumers receive and consume the benefits provided by the Company as the services are performed. As the Company has a right to consideration from Medicare commensurate with the services provided to customers from the performance completed over a given episodic period, the Company has elected to use the practical expedient for measuring progress toward satisfaction of performance obligations. Under this method recognizing revenue ratably over the episode based on beginning and ending dates is a reasonable proxy for the transfer of benefit of the service.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Allowance for Doubtful Accounts&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;For 2017, the Company established its allowance for doubtful accounts to the extent it was probable that a portion or all of a particular account will not be collected. The Company established its provision for doubtful accounts primarily by reviewing the creditworthiness of significant customers and through evaluations over the collectability of the receivables. An allowance for doubtful accounts was maintained at a level that the Company's management believed was sufficient to cover potential losses.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In 2018, subsequent adjustments that are determined to be the result of an adverse change in the payor's ability to pay are recognized as bad debt expense due to the adoption of ASU 2014-09, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Revenue from Contracts with Customers&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;. The Company recorded $&lt;font class="_mt"&gt;2.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;6.8&lt;/font&gt; million for the three and nine months ended September 30, 2018 as a reduction to revenue that would have been recorded as bad debt expense under the prior revenue recognition guidance.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Property and Equipment&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Property and equipment are recorded at cost and depreciated over the estimated useful lives of the related assets by use of the straight-line method. Maintenance and repairs are charged to expense as incurred. The estimated useful lives of the property and equipment are as follows:&lt;/font&gt;&lt;/p&gt;

&lt;div align="left"&gt;

&lt;table cellspacing="0" border="0"&gt;
&lt;tr&gt;&lt;td width="39%"&gt; &lt;/td&gt;
&lt;td width="60%"&gt; &lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer equipment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;3 &amp;#8211; 5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;
&lt;td align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 &amp;#8211; 7 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Transportation equipment&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Computer software&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: rgb(0,0,0) 1px solid;" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;5 &amp;#8211;10 years&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Lesser of useful life or lease term, unless&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr valign="bottom"&gt;&lt;td bgcolor="#ccffff" align="left"&gt;&amp;nbsp;&lt;/td&gt;
&lt;td bgcolor="#ccffff" align="right"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;probability of lease renewal is likely&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's carrying value of goodwill is the excess of the purchase price over the fair value of the net assets acquired from various acquisitions. In accordance with ASC Topic 350, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Goodwill and Other Intangible Assets&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;, goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. The Company may use a qualitative test, known as "Step 0," or a &lt;font class="_mt"&gt;two&lt;/font&gt;-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two-step analysis. In 2017, the Company elected to implement Step 0 and was not required to conduct the remaining two-step analysis. The results of the Company's Step 0 assessments indicated that it was more likely than not that the fair value of its reporting unit exceeded its carrying value and therefore the Company concluded that there were&amp;nbsp;&lt;font class="_mt"&gt;no&lt;/font&gt; impairments for the year ended December 31, 2017.&amp;nbsp;&lt;font class="_mt"&gt;No&lt;/font&gt; impairment charges were recorded for the three and nine months ended September 30, 2018 or 2017.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="margin: 0px;"&gt;&amp;nbsp;&lt;/p&gt;&lt;a name="page_10"&gt; &lt;/a&gt;&lt;br /&gt;

&lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Intangible Assets&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from&amp;nbsp;&lt;font class="_mt"&gt;two&lt;/font&gt; to&amp;nbsp;&lt;font class="_mt"&gt;twenty-five&lt;/font&gt; years.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Intangible assets with finite lives are amortized using the estimated economic benefit method over the useful life and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company would recognize an impairment loss when the estimated future non-discounted cash flows associated with the intangible asset is less than the carrying value. An impairment charge would then be recorded for the excess of the carrying value over the fair value.&amp;nbsp;&lt;font class="_mt"&gt;No&lt;/font&gt; impairment charge was recorded for the three and nine months ended September 30, 2018 and 2017.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company uses various valuation techniques to determine fair value of its intangible assets, including relief-from-royalty, income approach, discounted cash flow analysis, and multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about future market growth and trends, forecasted revenue and costs, expected periods over which the assets will be utilized, appropriate discount rates and other variables. The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Debt Issuance Costs&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method. The Company has classified the debt issuance costs as current portion of long-term debt or long-term debt, less current portion as of September 30, 2018 and December 31, 2017.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Workers' Compensation Program&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's workers' compensation insurance program has a $&lt;font class="_mt"&gt;0.4&lt;/font&gt; million deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis performed by an independent third party. The Company monitors its claims quarterly and adjusts its reserves accordingly. These costs are recorded primarily as the cost of services on the Company's Unaudited Condensed Consolidated Statements of Income. As of September 30, 2018 and December 31, 2017, the Company recorded $&lt;font class="_mt"&gt;14.8&lt;/font&gt; million and $&lt;font class="_mt"&gt;12.6&lt;/font&gt; million, respectively, in accrued workers' compensation insurance. The accrued workers' compensation insurance is included in accrued expenses on the Company's Unaudited Condensed Consolidated Balance Sheets. As of September 30, 2018 and December 31, 2017, the Company recorded $&lt;font class="_mt"&gt;1.4&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.5&lt;/font&gt; million, respectively, in workers' compensation insurance recovery receivables. The workers' compensation insurance recovery receivable is included in prepaid expenses and other current assets on the Company's Unaudited Condensed Consolidated Balance Sheets.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Interest Income&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Illinois law entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. The Company accounted for the interest income in accordance with ASC 606.&amp;nbsp;The interest income was recognized when the State of Illinois approved a prompt payment interest penalty during the nine months ended September 30, 2018, removing the constraint related to the amount and intent to pay the prompt payment interest. For the three months ended September 30, 2018, the Company did not receive any prompt payment interest. For the nine months ended September 30, 2018, the Company received $&lt;font class="_mt"&gt;2.3&lt;/font&gt; million in prompt payment interest and reported it in its Unaudited Condensed Consolidated Statements of Income as interest income. For the three and nine months ended September 30, 2017, the Company did &lt;font class="_mt"&gt;no&lt;/font&gt;t receive any prompt payment interest. While the Company may be owed additional prompt payment interest in the future, the amount, timing, and intent to provide receipt of such payments remains uncertain, and the Company will continue to recognize prompt payment interest income upon satisfaction of these constraints.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Interest Expense&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's interest expense consists of interest and unused credit line fees on its credit facilities, interest on its capital lease obligations, and amortization and write-off of debt issuance costs, which is reported in the statement of income when incurred.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Other Income&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Other income consisted of income distributions received from investments in joint ventures. The Company accounted for this income in accordance with ASC Topic 325, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Investments&amp;#8212;Other. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company recognized the net accumulated &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;earnings only to the extent distributed by the joint ventures on the date received. The Company subsequently sold these equity investments on October 1, 2017 (see Note 3).&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font size="2" class="_mt"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div class="MetaData"&gt;

&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Income Tax Expense&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company accounts for income taxes under the provisions of ASC Topic 740, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Income Taxes. &lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company's assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax asset will not be realized. ASC Topic 740 also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;div&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Stock-based Compensation&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company currently has&amp;nbsp;&lt;font class="_mt"&gt;one&lt;/font&gt; stock incentive plan, the 2017 Omnibus Incentive Plan (the "2017 Plan"), under which new grants of stock-based employee compensation may be made. In addition, the Company has outstanding awards under its 2009 Stock Incentive Plan, as amended and restated. The Company accounts for stock-based compensation in accordance with ASC Topic 718, &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Stock Compensation&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;. Under the 2017 Plan, compensation expense is recognized on a straight-line basis over the vesting period of the equity awards based on the grant date fair value of the options and restricted stock awards. The Company uses the Black-Scholes Option Pricing Model to value the Company's options. The determination of the fair value of stock-based payments utilizing the Black-Scholes Model is affected by the Company's stock price and a number of assumptions, including expected volatility, risk-free interest rate, expected term, and expected dividends yield. Stock-based compensation expense was $&lt;font class="_mt"&gt;1.1&lt;/font&gt; million and $&lt;font class="_mt"&gt;0.7&lt;/font&gt; million for the three months ended September 30, 2018 and 2017, respectively and $&lt;font class="_mt"&gt;3.0&lt;/font&gt; million and $&lt;font class="_mt"&gt;1.8&lt;/font&gt; million for the nine months ended September 30, 2018 and 2017, respectively.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Diluted Net Income Per Common Share&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company's outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Included in the Company's calculation of diluted earnings per share for the three and nine months ended September 30, 2018 were approximately&amp;nbsp;&lt;font class="_mt"&gt;708,000&lt;/font&gt; stock options outstanding, of which approximately&amp;nbsp;&lt;font class="_mt"&gt;307,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;213,000&lt;/font&gt; respectively, were dilutive. In addition, there were approximately&amp;nbsp;&lt;font class="_mt"&gt;148,000&lt;/font&gt; restricted stock awards outstanding&amp;nbsp;&lt;font class="_mt"&gt;83,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;83,000&lt;/font&gt; of which were dilutive for the three and nine months ended September 30, 2018, respectively.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Included in the Company's calculation of diluted earnings per share for the three and nine months ended September 30, 2017 were approximately&amp;nbsp;&lt;font class="_mt"&gt;479,000&lt;/font&gt; stock options outstanding, of which approximately&amp;nbsp;&lt;font class="_mt"&gt;102,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;102,000&lt;/font&gt; respectively, were dilutive. In addition, there were approximately&amp;nbsp;&lt;font class="_mt"&gt;148,000&lt;/font&gt; restricted stock awards outstanding&amp;nbsp;&lt;font class="_mt"&gt;43,000&lt;/font&gt; and&amp;nbsp;&lt;font class="_mt"&gt;50,000&lt;/font&gt; of which were dilutive for the three and nine months ended September 30, 2017, respectively.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Shareholders' Equity&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On August 20, 2018, the Company, together with Eos Capital Partners III, L.P. (the "Selling Stockholder") completed a secondary public offering of an aggregate&amp;nbsp;&lt;font class="_mt"&gt;2,100,000&lt;/font&gt; shares of common stock, par value $&lt;font class="_mt"&gt;0.001&lt;/font&gt; per share at a purchase price per share to the public of $&lt;font class="_mt"&gt;59.00&lt;/font&gt;. Pursuant to the terms and conditions of the Underwriting Agreement,&amp;nbsp;&lt;font class="_mt"&gt;1,075,267&lt;/font&gt; shares of Common Stock were issued and sold by the Company (the "Primary Shares") and&amp;nbsp;&lt;font class="_mt"&gt;1,024,733&lt;/font&gt; shares of Common Stock were sold by the Selling Stockholder (the "Secondary Shares"). The Company received net proceeds of approximately $&lt;font class="_mt"&gt;59.1&lt;/font&gt; million from the sale of 1,075,267 Primary Shares. On August 22, 2018, the underwriters exercised their full over-allotment option in connection with the offering and, as a result, the Company issued and sold an additional&amp;nbsp;&lt;font class="_mt"&gt;315,000&lt;/font&gt; shares of common stock to the underwriters at the Public Offering Price, less the underwriting discount. The over-allotment resulted in additional net proceeds to the Company of approximately $&lt;font class="_mt"&gt;17.5&lt;/font&gt; million. The Company intends to use the net proceeds from the offering &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;for general corporate purposes, including to potentially fund a portion of any future acquisitions that the Company may complete. The Company did not receive any of the proceeds from the sale of the Secondary Shares. The secondary offering resulted in an increase to additional paid in capital of approximately $&lt;font class="_mt"&gt;76.6&lt;/font&gt; million, net of issuance costs of $&lt;font class="_mt"&gt;5.4&lt;/font&gt; million, on the Company's Unaudited Condensed Consolidated Balance Sheets at September 30, 2018.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Estimates&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company's critical accounting estimates include the &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;following areas: the implicit price concessions factored into net service revenues, allowance for doubtful accounts, reserve for self-insurance claims, accounting for stock-based compensation, accounting for income taxes, business combinations and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Fair Value Measurements&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company's financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported on the Company's Unaudited Condensed Consolidated Balance Sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company's long-term debt with variable interest rates approximates fair value based on instruments with similar terms using level 2 inputs as defined under ASC Topic 820 &lt;/font&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-ItalicMT,Times New Roman,Times,serif;" size="2"&gt;Fair Value Measurement&lt;/font&gt;&lt;/i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill, if required, and indefinite-lived intangible assets and also when determining the fair value of contingent consideration, if applicable. To determine the fair value in these situations, the Company uses Level 3 inputs, under ASC Topic 820 and defined as unobservable inputs in which little or no market data exists; therefore requiring an entity to develop its own assumptions, such as discounted cash flows, or if available, what a market participant would pay on the measurement date.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The Company uses various valuation techniques to determine fair value of its intangible assets, including relief-from-royalty, income approach, discounted cash flow analysis, and multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about future market growth and trends, forecasted revenue and costs, expected periods over which the assets will be utilized, appropriate discount rates and other variables.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;

&lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Going Concern&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;In connection with the preparation of the financial statements for the three and nine months ended September 30, 2018 and 2017, the Company conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to the entity's ability to continue as a going concern within one year after the date of the issuance, or the date of availability, of the financial statements to be issued. The evaluation concluded that there did not appear to be evidence of substantial doubt of the entity's ability to continue as a going concern.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;

&lt;p style="text-align: left;"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt; &lt;/font&gt;&amp;nbsp;&lt;/p&gt; &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:StockholdersEquity id="Item-869" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">175080000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Item-867" contextRef="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="-3">95963000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Item-866" contextRef="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="-3">12000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Item-868" contextRef="As_Of_12_31_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="-3">79105000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Item-887" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">267810000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Item-885" contextRef="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="-3">175991000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Item-884" contextRef="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="-3">13000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="Item-886" contextRef="As_Of_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit1" decimals="-3">91806000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityPolicyTextBlock id="Item-738" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;
&lt;/font&gt;
&lt;div&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Shareholders' Equity&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On August 20, 2018, the Company, together with Eos Capital Partners III, L.P. (the "Selling Stockholder") completed a secondary public offering of an aggregate&amp;nbsp;&lt;font class="_mt"&gt;2,100,000&lt;/font&gt; shares of common stock, par value $&lt;font class="_mt"&gt;0.001&lt;/font&gt; per share at a purchase price per share to the public of $&lt;font class="_mt"&gt;59.00&lt;/font&gt;. Pursuant to the terms and conditions of the Underwriting Agreement,&amp;nbsp;&lt;font class="_mt"&gt;1,075,267&lt;/font&gt; shares of Common Stock were issued and sold by the Company (the "Primary Shares") and&amp;nbsp;&lt;font class="_mt"&gt;1,024,733&lt;/font&gt; shares of Common Stock were sold by the Selling Stockholder (the "Secondary Shares"). The Company received net proceeds of approximately $&lt;font class="_mt"&gt;59.1&lt;/font&gt; million from the sale of 1,075,267 Primary Shares. On August 22, 2018, the underwriters exercised their full over-allotment option in connection with the offering and, as a result, the Company issued and sold an additional&amp;nbsp;&lt;font class="_mt"&gt;315,000&lt;/font&gt; shares of common stock to the underwriters at the Public Offering Price, less the underwriting discount. The over-allotment resulted in additional net proceeds to the Company of approximately $&lt;font class="_mt"&gt;17.5&lt;/font&gt; million. The Company intends to use the net proceeds from the offering &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;for general corporate purposes, including to potentially fund a portion of any future acquisitions that the Company may complete. The Company did not receive any of the proceeds from the sale of the Secondary Shares. The secondary offering resulted in an increase to additional paid in capital of approximately $&lt;font class="_mt"&gt;76.6&lt;/font&gt; million, net of issuance costs of $&lt;font class="_mt"&gt;5.4&lt;/font&gt; million, on the Company's Unaudited Condensed Consolidated Balance Sheets at September 30, 2018.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Item-877" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit16" decimals="-3">1390000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Item-744" contextRef="Duration_8_20_2018_To_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_PrimarySharesMember" unitRef="Unit16" decimals="INF">1075267</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Item-710" contextRef="Duration_8_20_2018_To_8_20_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_SecondaryPublicOfferingMember" unitRef="Unit16" decimals="INF">2100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Item-709" contextRef="Duration_8_20_2018_To_8_20_2018_dei_LegalEntityAxis_adus_EosCapitalPartnersMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_adus_SecondarySharsMember" unitRef="Unit16" decimals="INF">1024733</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="Item-755" contextRef="Duration_8_22_2018_To_8_22_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_OverAllotmentOptionMember" unitRef="Unit16" decimals="INF">315000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross id="Item-870" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit16" decimals="-3">74000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
  <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures id="Item-871" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit16" decimals="-3">16000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="Item-874" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit16" decimals="-3">17000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Item-880" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">76618000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Item-879" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="-3">76617000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="Item-878" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="-3">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Item-876" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit1" decimals="-3">450000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised id="Item-875" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit1" decimals="-3">450000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
  <us-gaap:SubsequentEventsTextBlock id="Item-888" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldMT,Times New Roman,Times,serif;" size="2"&gt;14. Subsequent Events&lt;/font&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On October 31, 2018, the Company amended and restated its existing Credit Agreement with certain lenders and Capital One, N.A as a lender and swing line lender and as agent for all lenders. See Note 7, "Amended and Restated Senior Secured Credit Facility" for additional information.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;Effective October 31, 2018, the Company entered into a definitive agreement to acquire the assets of VIP Health Care Services for approximately&amp;nbsp;&lt;font class="_mt"&gt;$28.0&lt;/font&gt; million. The Company expects to complete this transaction in the first or second quarter of 2019, contingent on the timing of certain regulatory approvals. The Company expects to fund this acquisition through the delayed draw term loan portion of its new credit facility and available cash on hand.&lt;/font&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;On November 5, 2018 we amended and restated the employment agreements of each of our named executive officers in order to: (i) increase the amount of severance that would be payable on certain terminations of employment in connection with a change in control (as defined in the employment agreements), from two times annual compensation to three times annual compensation (as defined in the employment agreements) in the case of our chief executive officer, and from one times annual compensation to two times annual compensation (as defined in the employment agreements) in the case of our other named executive officers; (ii) provide that the enhanced severance for terminations of employment in connection with a change in control would be payable if the named executive officers self-terminated for good reason (as defined in the employment agreements); (iii) stipulate that severance for terminations of employment in connection with a change in control would include any unpaid bonus for a performance period completed prior to termination (the chief executive officer already had this right); and (iv) adjust the duration of non-competition and non-solicitation periods to match the number of years of annual compensation that the named executive officer would receive in severance. Copies of these employment agreements are attached to this Quarterly Report on&amp;nbsp;10-Q as Exhibits 10.3 through 10.8, and are incorporated herein by reference.&lt;/font&gt;&lt;/p&gt; &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <us-gaap:UseOfEstimates id="Item-726" contextRef="Duration_1_1_2018_To_9_30_2018">&lt;div&gt; &lt;div class="MetaData"&gt;

&lt;p style="text-align: left;"&gt;&lt;b&gt;&lt;i&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPS-BoldItalicMT,Times New Roman,Times,serif;" size="2"&gt;Estimates&lt;/font&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="text-align: left;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company's critical accounting estimates include the &lt;/font&gt;&lt;font class="_mt" style="font-family: TimesNewRomanPSMT,Times New Roman,Times,serif;" size="2"&gt;following areas: the implicit price concessions factored into net service revenues, allowance for doubtful accounts, reserve for self-insurance claims, accounting for stock-based compensation, accounting for income taxes, business combinations and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.&lt;/font&gt;&lt;/p&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-751" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit16" decimals="-3">102000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-698" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit16" decimals="-3">50000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-712" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit16" decimals="-3">102000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-748" contextRef="Duration_7_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit16" decimals="-3">43000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-754" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit16" decimals="-3">213000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-746" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit16" decimals="-3">83000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-714" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit16" decimals="-3">307000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment id="Item-737" contextRef="Duration_7_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit16" decimals="-3">83000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="Item-441" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit16" decimals="-3">11616000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="Item-439" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit16" decimals="-3">11631000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="Item-440" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit16" decimals="-3">12037000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding id="Item-438" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit16" decimals="-3">12569000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Item-437" contextRef="Duration_1_1_2017_To_9_30_2017" unitRef="Unit16" decimals="-3">11464000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Item-435" contextRef="Duration_7_1_2017_To_9_30_2017" unitRef="Unit16" decimals="-3">11486000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Item-436" contextRef="Duration_1_1_2018_To_9_30_2018" unitRef="Unit16" decimals="-3">11740000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic id="Item-434" contextRef="Duration_7_1_2018_To_9_30_2018" unitRef="Unit16" decimals="-3">12179000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesRestrictedStock id="Item-725" contextRef="Duration_1_1_2017_To_9_30_2017_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit16" decimals="-3">148000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
  <us-gaap:WeightedAverageNumberOfSharesRestrictedStock id="Item-700" contextRef="Duration_1_1_2018_To_9_30_2018_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit16" decimals="-3">148000</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
  <us-gaap:WorkersCompensationLiabilityCurrent id="Item-163" contextRef="As_Of_12_31_2017" unitRef="Unit1" decimals="-3">12574000</us-gaap:WorkersCompensationLiabilityCurrent>
  <us-gaap:WorkersCompensationLiabilityCurrent id="Item-162" contextRef="As_Of_9_30_2018" unitRef="Unit1" decimals="-3">14846000</us-gaap:WorkersCompensationLiabilityCurrent>
  <!--Extensible List Section-->
  <!--Footnote Section-->
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="#Item-165" xlink:label="Item-165_lbl" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-165_lbl" xlink:to="Footnote-01" order="1" />
    <link:loc xlink:type="locator" xlink:href="#Item-164" xlink:label="Item-164_lbl" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-164_lbl" xlink:to="Footnote-01" order="1" />
    <link:loc xlink:type="locator" xlink:href="#Item-462" xlink:label="Item-462_lbl" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-462_lbl" xlink:to="Footnote-02" order="1" />
    <link:loc xlink:type="locator" xlink:href="#Item-463" xlink:label="Item-463_lbl" />
    <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Item-463_lbl" xlink:to="Footnote-03" order="1" />
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">The Company provides health insurance coverage to qualified union employees providing personal care services in Illinois through a Taft-Hartley multi-employer health and welfare plan under Section 302(c)(5) of the Labor Management Relations Act of 1947. The Company's insurance contributions equal the amount reimbursed by the State of Illinois. Contributions are due within five business days from the date the funds are received from the State of Illinois. Amounts due of $1.2 million and $2.3 million for health insurance reimbursements and contributions were reflected in prepaid insurance and accrued insurance as of September 30, 2018 and December 31, 2017, respectively.</link:footnote>
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">

Amount necessary to reduce net minimum lease payments to present value calculated at the Company's incremental borrowing rate at lease inception.</link:footnote>
    <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Included in the balance sheet as $114,000 of the current portion of long-term debt and $28,000 of the long-term debt, less current portion.</link:footnote>
  </link:footnoteLink>
</xbrl>

